Multiple	O
p21ras	B-protein
effector	O
pathways	O
regulate	O
nuclear	O
factor	O
of	O
activated	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

The	O
transcription	B-protein
factor	I-protein
,	O
Nuclear	B-protein
Factor	I-protein
of	I-protein
Activated	I-protein
T	I-protein
cells	I-protein
(	O
NFAT	B-protein
)	O
is	O
a	O
major	O
target	O
for	O
p21ras	B-protein
and	O
calcium	O
signalling	O
pathways	O
in	O
the	O
IL-2	B-DNA
gene	I-DNA
and	O
is	O
induced	O
by	O
p21ras	B-protein
signals	O
acting	O
in	O
synergy	O
with	O
calcium	O
/calcineurin	B-protein
signals	O
.	O

One	O
p21ras	B-protein
effector	O
pathway	O
involves	O
the	O
MAP	B-protein
kinase	I-protein
ERK-2	B-protein
,	O
and	O
we	O
have	O
examined	O
its	O
role	O
in	O
NFAT	B-protein
regulation	O
.	O

Expression	O
of	O
dominant	B-protein
negative	I-protein
MAPKK-1	I-protein
prevents	O
NFAT	B-protein
induction	O
.	O

Constitutively	O
active	O
MAPKK-1	B-protein
fully	O
activates	O
ERK-2	B-protein
and	O
the	O
transcription	B-protein
factor	I-protein
Elk-1	B-protein
,	O
but	O
does	O
not	O
substitute	O
for	O
activated	O
p21ras	B-protein
and	O
synergize	O
with	O
calcium	O
/calcineurin	B-protein
signals	O
to	O
induce	O
NFAT	B-protein
.	O

Expression	O
of	O
dominant	B-protein
negative	I-protein
N17Rac	I-protein
also	O
prevents	O
TCR	B-protein
and	O
p21ras	B-protein
activation	O
of	O
NFAT	B-protein
,	O
but	O
without	O
interfering	O
with	O
the	O
ERK-2	B-protein
pathway	O
.	O

The	O
transcriptional	O
activity	O
of	O
the	O
NFAT	B-DNA
binding	I-DNA
site	I-DNA
is	O
mediated	O
by	O
a	O
complex	O
comprising	O
a	O
member	O
of	O
the	O
NFAT	B-protein
group	O
and	O
AP-1	B-protein
family	I-protein
proteins	I-protein
.	O

The	O
induction	O
of	O
AP-1	B-protein
by	O
p21ras	B-protein
also	O
requires	O
Rac-1	B-protein
function	O
.	O

Activated	B-protein
Rac-1	I-protein
could	O
mimic	O
activated	B-protein
p21ras	I-protein
to	O
induce	O
AP-1	B-protein
but	O
not	O
to	O
induce	O
NFAT	B-protein
.	O

Moreover	O
,	O
the	O
combination	O
of	O
activated	O
MAPKK-1	B-protein
and	O
Rac-1	B-protein
could	O
not	O
substitute	O
for	O
activated	O
p21ras	B-protein
and	O
synergize	O
with	O
calcium	O
signals	O
to	O
induce	O
NFAT	B-protein
.	O

Thus	O
,	O
p21ras	B-protein
regulation	O
of	O
NFAT	B-protein
in	O
T	B-cell_type
cells	I-cell_type
requires	O
the	O
activity	O
of	O
multiple	O
effector	O
pathways	O
including	O
those	O
regulated	O
by	O
MAPKK-1	B-protein
/ERK-2	B-protein
and	O
Rac-1	B-protein
.	O

The	NULL
EMBO	NULL
Journal	NULL
vol.15	NULL
no.15	NULL
pp.3923-3933	NULL
,	NULL
1996	NULL
Multiple	NULL
p21ras	NULL
effector	NULL
pathways	NULL
regulate	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
Elisabeth	NULL
Genot	NULL
'	NULL
,	NULL
Steve	NULL
Cleverley	NULL
,	NULL
Stefan	NULL
Henning	NULL
and	NULL
Doreen	NULL
Cantrell	NULL
Lymphocyte	NULL
Activation	NULL
Laboratory	NULL
.	NULL

Imperial	NULL
Cancer	NULL
Research	NULL
Fund	NULL
,	NULL
44	NULL
Lincoln	NULL
's	NULL
Inn	NULL
Fields	NULL
.	NULL

London	NULL
WC2A	NULL
3PX	NULL
,	NULL
UK	NULL
'Corresponding	NULL
author	NULL
The	NULL
transcription	NULL
factor	NULL
,	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
is	NULL
a	NULL
major	NULL
target	NULL
for	NULL
p21ras	NULL
and	NULL
calcium	NULL
signalling	NULL
pathways	NULL
in	NULL
the	NULL
IL-2	NULL
gene	NULL
and	NULL
is	NULL
induced	NULL
by	NULL
p2lras	NULL
signals	NULL
acting	NULL
in	NULL
synergy	NULL
with	NULL
calcium/	NULL
calcineurin	NULL
signals	NULL
.	NULL

One	NULL
p2lras	NULL
effector	NULL
pathway	NULL
involves	NULL
the	NULL
MAP	NULL
kinase	NULL
ERK-2	NULL
,	NULL
and	NULL
we	NULL
have	NULL
examined	NULL
its	NULL
role	NULL
in	NULL
NFAT	NULL
regulation	NULL
.	NULL

Expression	NULL
of	NULL
dominant	NULL
negative	NULL
MAPKK-1	NULL
prevents	NULL
NFAT	NULL
induction	NULL
.	NULL

Constitutively	NULL
active	NULL
MAPKK-1	NULL
fully	NULL
activates	NULL
ERK-2	NULL
and	NULL
the	NULL
transcription	NULL
factor	NULL
Elk-1	NULL
,	NULL
but	NULL
does	NULL
not	NULL
substitute	NULL
for	NULL
activated	NULL
p2lras	NULL
and	NULL
synergize	NULL
with	NULL
calcium/	NULL
calcineurin	NULL
signals	NULL
to	NULL
induce	NULL
NFAT	NULL
.	NULL

Expression	NULL
of	NULL
dominant	NULL
negative	NULL
N17Rac	NULL
also	NULL
prevents	NULL
TCR	NULL
and	NULL
p2lras	NULL
activation	NULL
of	NULL
NFAT	NULL
,	NULL
but	NULL
without	NULL
interfering	NULL
with	NULL
the	NULL
ERK-2	NULL
pathway	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
complex	NULL
comprising	NULL
a	NULL
member	NULL
of	NULL
the	NULL
NFAT	NULL
group	NULL
and	NULL
AP-1	NULL
family	NULL
proteins	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
AP-1	NULL
by	NULL
p21ras	NULL
also	NULL
requires	NULL
Rac-1	NULL
function	NULL
.	NULL

Activated	NULL
Rac-1	NULL
could	NULL
mimic	NULL
activated	NULL
p2lras	NULL
to	NULL
induce	NULL
AP-1	NULL
but	NULL
not	NULL
to	NULL
induce	NULL
NFAT	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
activated	NULL
MAPKK-1	NULL
and	NULL
Rac-1	NULL
could	NULL
not	NULL
substitute	NULL
for	NULL
activated	NULL
p2lras	NULL
and	NULL
synergize	NULL
with	NULL
calcium	NULL
signals	NULL
to	NULL
induce	NULL
NFAT	NULL
.	NULL

Thus	NULL
,	NULL
p2lras	NULL
regulation	NULL
of	NULL
NFAT	NULL
in	NULL
T	NULL
cells	NULL
requires	NULL
the	NULL
activity	NULL
of	NULL
multiple	NULL
effector	NULL
pathways	NULL
including	NULL
those	NULL
regulated	NULL
by	NULL
MAPKK-1/ERK-2	NULL
and	NULL
Rac-1	NULL
.	NULL

Keywords	NULL
:	NULL
NFAT/Rac-1/Ras/MAPKK-1/transduction/	NULL
TCR	NULL
Introduction	NULL
The	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
controls	NULL
activation	NULL
and	NULL
the	NULL
GO-G1	NULL
transition	NULL
of	NULL
T	NULL
lymphocytes	NULL
and	NULL
regulates	NULL
the	NULL
production	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cytokines	NULL
,	NULL
including	NULL
the	NULL
growth	NULL
factor	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
IL-2	NULL
production	NULL
by	NULL
the	NULL
TCR	NULL
requires	NULL
the	NULL
co-ordinate	NULL
action	NULL
of	NULL
multiple	NULL
transcription	NULL
factors	NULL
that	NULL
include	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
,	NULL
AP-1	NULL
,	NULL
NF-xB	NULL
and	NULL
Oct-	NULL
!	NULL

(	NULL
Schreiber	NULL
and	NULL
Crabtree	NULL
,	NULL
1992	NULL
;	NULL
Rao	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
intracellular	NULL
signals	NULL
that	NULL
regulate	NULL
these	NULL
different	NULL
transcription	NULL
factors	NULL
involve	NULL
tyrosine	NULL
-	NULL
kinase-induced	NULL
-	NULL
calcium/calcineurin	NULL
,	NULL
-	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
and	NULL
p21ras-mediated	NULL
signalling	NULL
pathways	NULL
(	NULL
Weiss	NULL
and	NULL
Littman	NULL
,	NULL
1994	NULL
;	NULL
Izquierdo-Pastor	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
p21ras	NULL
function	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
expression	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
p2lras	NULL
mutant	NULL
prevents	NULL
induction	NULL
of	NULL
Â©	NULL
Oxford	NULL
University	NULL
Press	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
Baldari	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Rayter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
major	NULL
target	NULL
in	NULL
the	NULL
IL-2	NULL
gene	NULL
for	NULL
p2lras	NULL
signalling	NULL
pathways	NULL
is	NULL
NFAT	NULL
(	NULL
Woodrow	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993b	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
constitutively	NULL
active	NULL
Ras	NULL
mutant	NULL
(	NULL
p21-v-Ha-ras	NULL
)	NULL
,	NULL
when	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
can	NULL
synergize	NULL
with	NULL
a	NULL
calcium/	NULL
calcineurin	NULL
-	NULL
signalling	NULL
pathway	NULL
to	NULL
activate	NULL
NFAT	NULL
(	NULL
Woodrow	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993a	NULL
,	NULL
b	NULL
)	NULL
.	NULL

p21ras	NULL
regulatory	NULL
effects	NULL
on	NULL
NFAT	NULL
can	NULL
be	NULL
mimicked	NULL
by	NULL
phorbol	NULL
esters	NULL
that	NULL
activate	NULL
PKC	NULL
or	NULL
by	NULL
expression	NULL
of	NULL
constitutively	NULL
activated	NULL
mutants	NULL
of	NULL
PKC	NULL
(	NULL
Genot	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
phorbol	NULL
esters	NULL
to	NULL
activate	NULL
p21ras	NULL
in	NULL
T	NULL
cells	NULL
led	NULL
to	NULL
the	NULL
proposal	NULL
that	NULL
PKC	NULL
effects	NULL
on	NULL
NFAT	NULL
were	NULL
mediated	NULL
by	NULL
p21ras	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
now	NULL
recognized	NULL
that	NULL
phorbol	NULL
ester	NULL
and	NULL
p21ras	NULL
induction	NULL
of	NULL
NFAT	NULL
occur	NULL
by	NULL
different	NULL
,	NULL
independent	NULL
mechanisms	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
p2lras	NULL
but	NULL
not	NULL
PKC	NULL
signals	NULL
are	NULL
essential	NULL
for	NULL
TCR	NULL
induction	NULL
of	NULL
NFAT	NULL
(	NULL
Williams	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

NFAT	NULL
proteins	NULL
are	NULL
cytosolic	NULL
in	NULL
quiescent	NULL
T	NULL
cells	NULL
but	NULL
they	NULL
trans-locate	NULL
to	NULL
the	NULL
nucleus	NULL
in	NULL
TCR-activated	NULL
cells	NULL
and	NULL
combine	NULL
with	NULL
newly	NULL
induced	NULL
AP-1	NULL
complexes	NULL
to	NULL
form	NULL
a	NULL
functional	NULL
transcriptional	NULL
factor	NULL
unit	NULL
(	NULL
Flanagan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

There	NULL
are	NULL
multiple	NULL
isoforms	NULL
of	NULL
the	NULL
NFAT	NULL
cytosolic	NULL
subunit	NULL
,	NULL
NFATc	NULL
,	NULL
NFATp	NULL
,	NULL
NFAT3	NULL
and	NULL
NFAT4	NULL
,	NULL
that	NULL
have	NULL
different	NULL
patterns	NULL
of	NULL
cellular	NULL
expression	NULL
but	NULL
are	NULL
thought	NULL
to	NULL
share	NULL
one	NULL
property	NULL
in	NULL
that	NULL
their	NULL
nuclear	NULL
translocation	NULL
is	NULL
controlled	NULL
by	NULL
calcium/calcineurin-dependent	NULL
signals	NULL
(	NULL
Northrop	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Rao	NULL
,	NULL
1994	NULL
;	NULL
Hoey	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
different	NULL
NFAT	NULL
proteins	NULL
also	NULL
share	NULL
the	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
AP-1	NULL
to	NULL
bind	NULL
co-operatively	NULL
to	NULL
the	NULL
composite	NULL
NFAT/AP-1	NULL
site	NULL
in	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
Rao	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
interaction	NULL
with	NULL
AP-1	NULL
is	NULL
essential	NULL
for	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
,	NULL
and	NULL
the	NULL
role	NULL
of	NULL
p2lras	NULL
in	NULL
NFAT	NULL
induction	NULL
has	NULL
been	NULL
explained	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
p2lras	NULL
signals	NULL
to	NULL
stimulate	NULL
AP-1	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
Rayter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Woodrow	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993a	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
p2lras	NULL
effector	NULL
pathways	NULL
involved	NULL
in	NULL
NFAT	NULL
regulation	NULL
have	NULL
not	NULL
been	NULL
defined	NULL
and	NULL
are	NULL
the	NULL
focus	NULL
of	NULL
the	NULL
present	NULL
report	NULL
.	NULL

T	NULL
lymphocytes	NULL
express	NULL
at	NULL
least	NULL
two	NULL
MAP	NULL
kinases	NULL
,	NULL
ERK-1	NULL
and	NULL
ERK-2	NULL
,	NULL
that	NULL
are	NULL
stimulated	NULL
by	NULL
a	NULL
p21lras	NULL
pathway	NULL
in	NULL
response	NULL
to	NULL
TCR	NULL
triggering	NULL
(	NULL
Izquierdo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
MAP	NULL
kinases	NULL
are	NULL
activated	NULL
by	NULL
a	NULL
kinase	NULL
cascade	NULL
involving	NULL
a	NULL
MAP	NULL
kinase	NULL
kinase	NULL
(	NULL
MAPKK	NULL
)	NULL
that	NULL
phos-phorylates	NULL
and	NULL
stimulates	NULL
the	NULL
ERK-1	NULL
and	NULL
-2	NULL
kinases	NULL
directly	NULL
(	NULL
Marshall	NULL
,	NULL
1994	NULL
;	NULL
Cobb	NULL
and	NULL
Goldsmith	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
MAPKK	NULL
is	NULL
itself	NULL
controlled	NULL
by	NULL
phosphorylation	NULL
and	NULL
,	NULL
hence	NULL
,	NULL
a	NULL
MAP	NULL
kinase	NULL
kinase	NULL
kinase	NULL
(	NULL
MAPKKK	NULL
)	NULL
regulates	NULL
ERK-1	NULL
and	NULL
-2	NULL
.	NULL

Raf-1	NULL
is	NULL
a	NULL
p21lras	NULL
effector	NULL
that	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
MAPKKK	NULL
that	NULL
couples	NULL
p2lras	NULL
and	NULL
hence	NULL
receptors	NULL
to	NULL
the	NULL
MAP	NULL
kinases	NULL
(	NULL
Howe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Warne	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Izquierdo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994a	NULL
;	NULL
Leevers	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
neuronal	NULL
cells	NULL
,	NULL
MAPKK-1	NULL
and	NULL
ERK-1	NULL
,	NULL
-2	NULL
are	NULL
critical	NULL
mediators	NULL
of	NULL
p2Iras	NULL
functions	NULL
(	NULL
Cowley	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

One	NULL
regulatory	NULL
substrate	NULL
for	NULL
the	NULL
ERKs	NULL
is	NULL
the	NULL
protein	NULL
Elk-1	NULL
,	NULL
which	NULL
is	NULL
one	NULL
of	NULL
a	NULL
family	NULL
of	NULL
proteins	NULL
that	NULL
can	NULL
form	NULL
a	NULL
ternary	NULL
complex	NULL
with	NULL
the	NULL
transcriptional	NULL
activator	NULL
serum	NULL
3923	NULL
E.Genot	NULL
et	NULL
al	NULL
.	NULL

response	NULL
factor	NULL
(	NULL
SRF	NULL
)	NULL
(	NULL
Marais	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Elk-1-SRF	NULL
complexes	NULL
are	NULL
necessary	NULL
and	NULL
sufficient	NULL
mediators	NULL
of	NULL
c-fos	NULL
serum	NULL
response	NULL
element	NULL
induction	NULL
.	NULL

Thus	NULL
,	NULL
p21ras	NULL
regulation	NULL
of	NULL
the	NULL
MAPKK/ERK	NULL
pathway	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
regulating	NULL
c-fos	NULL
gene	NULL
expression	NULL
(	NULL
Hill	NULL
and	NULL
Treisman	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
analysis	NULL
of	NULL
the	NULL
role	NULL
of	NULL
the	NULL
ERKs	NULL
in	NULL
the	NULL
control	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
fibroblasts	NULL
has	NULL
created	NULL
a	NULL
paradigm	NULL
that	NULL
the	NULL
MAPKK/ERK	NULL
pathway	NULL
is	NULL
a	NULL
major	NULL
route	NULL
whereby	NULL
p2lras	NULL
regulates	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
immediate	NULL
early	NULL
genes	NULL
such	NULL
as	NULL
c-fos	NULL
.	NULL

By	NULL
analogy	NULL
,	NULL
there	NULL
is	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
p21ras/MAPKK	NULL
pathway	NULL
is	NULL
the	NULL
p21ras	NULL
effector	NULL
pathway	NULL
for	NULL
NFAT	NULL
induction	NULL
.	NULL

There	NULL
has	NULL
been	NULL
one	NULL
previous	NULL
study	NULL
on	NULL
the	NULL
role	NULL
of	NULL
MAPKK	NULL
and	NULL
the	NULL
ERKs	NULL
as	NULL
p21	NULL
ras	NULL
effectors	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
this	NULL
was	NULL
a	NULL
study	NULL
in	NULL
transgenic	NULL
mice	NULL
that	NULL
showed	NULL
that	NULL
expression	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
MAPKK-1	NULL
mutant	NULL
could	NULL
mimic	NULL
inhibitory	NULL
p21ras	NULL
mutants	NULL
and	NULL
suppress	NULL
positive	NULL
selection	NULL
of	NULL
thymocytes	NULL
(	NULL
Alberola-lla	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

However	NULL
,	NULL
dominant	NULL
negative	NULL
Ras	NULL
mutants	NULL
can	NULL
prevent	NULL
the	NULL
in	NULL
vitro	NULL
proliferation	NULL
of	NULL
thymocytes	NULL
,	NULL
whereas	NULL
a	NULL
dominant	NULL
negative	NULL
MAPKK-1	NULL
mutant	NULL
does	NULL
not	NULL
,	NULL
indicating	NULL
that	NULL
not	NULL
all	NULL
Ras	NULL
functions	NULL
in	NULL
T	NULL
cells	NULL
are	NULL
mediated	NULL
by	NULL
the	NULL
MAP	NULL
kinases	NULL
cascade	NULL
.	NULL

The	NULL
Ras-related	NULL
GTPase	NULL
Rac-1	NULL
has	NULL
been	NULL
described	NULL
recently	NULL
as	NULL
another	NULL
downstream	NULL
effector	NULL
of	NULL
p21ras	NULL
(	NULL
Hall	NULL
,	NULL
1994	NULL
;	NULL
Qiu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
Accordingly	NULL
,	NULL
the	NULL
object	NULL
of	NULL
the	NULL
present	NULL
study	NULL
was	NULL
to	NULL
explore	NULL
the	NULL
signalling	NULL
connections	NULL
between	NULL
p21ras	NULL
,	NULL
the	NULL
MAPKK/ERK	NULL
cascade	NULL
and	NULL
Rac-1	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
these	NULL
proteins	NULL
in	NULL
p2	NULL
1ras	NULL
regulation	NULL
of	NULL
NFAT	NULL
.	NULL

The	NULL
data	NULL
show	NULL
that	NULL
expression	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
MAPKK-1	NULL
mutant	NULL
can	NULL
inhibit	NULL
NFAT	NULL
induction	NULL
,	NULL
but	NULL
expression	NULL
of	NULL
a	NULL
constitutively	NULL
active	NULL
MAPKK-1	NULL
mutant	NULL
,	NULL
which	NULL
could	NULL
activate	NULL
ERK-2	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
could	NULL
not	NULL
substitute	NULL
for	NULL
constitutively	NULL
active	NULL
p21lras	NULL
and	NULL
synergize	NULL
with	NULL
calcium-dependent	NULL
signals	NULL
to	NULL
induce	NULL
NFAT	NULL
.	NULL

These	NULL
studies	NULL
collectively	NULL
suggest	NULL
that	NULL
the	NULL
ERK	NULL
pathway	NULL
is	NULL
a	NULL
necessary	NULL
but	NULL
not	NULL
sufficient	NULL
p2lras	NULL
effector	NULL
pathway	NULL
for	NULL
NFAT	NULL
induction	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Expression	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
Rac-1	NULL
mutant	NULL
had	NULL
a	NULL
pronounced	NULL
inhibitory	NULL
effect	NULL
on	NULL
Ras	NULL
induction	NULL
of	NULL
NFAT	NULL
,	NULL
which	NULL
suggests	NULL
that	NULL
Rac-1	NULL
is	NULL
an	NULL
effector	NULL
for	NULL
p21ras	NULL
in	NULL
NFAT	NULL
regulation	NULL
.	NULL

In	NULL
fibroblasts	NULL
,	NULL
Rac-1	NULL
-mediated	NULL
intracellular	NULL
signals	NULL
participate	NULL
in	NULL
activation	NULL
of	NULL
Jun	NULL
kinases	NULL
and	NULL
transactivation	NULL
of	NULL
c-jun	NULL
in	NULL
a	NULL
mechanism	NULL
analogous	NULL
to	NULL
p2lras	NULL
regulation	NULL
of	NULL
ERK-2-Elk-1	NULL
(	NULL
Minden	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
present	NULL
data	NULL
show	NULL
that	NULL
expression	NULL
of	NULL
constitutively	NULL
active	NULL
Rac-1	NULL
can	NULL
stimulate	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
demonstrating	NULL
that	NULL
Rac-1	NULL
can	NULL
also	NULL
stimulate	NULL
transcription	NULL
factor	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
constitutively	NULL
active	NULL
Rac-l	NULL
mutants	NULL
could	NULL
not	NULL
synergize	NULL
with	NULL
calcium	NULL
signals	NULL
to	NULL
induce	NULL
NFAT	NULL
,	NULL
indicating	NULL
that	NULL
Rac-1	NULL
is	NULL
necessary	NULL
but	NULL
not	NULL
sufficient	NULL
for	NULL
all	NULL
p21	NULL
ras-mediated	NULL
signalling	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Accordingly	NULL
,	NULL
p2iras	NULL
effects	NULL
on	NULL
NFAT	NULL
are	NULL
not	NULL
mediated	NULL
by	NULL
a	NULL
single	NULL
linear	NULL
signalling	NULL
pathway	NULL
but	NULL
must	NULL
involve	NULL
multiple	NULL
effectors	NULL
that	NULL
include	NULL
Rac-i	NULL
and	NULL
MAPKK-1	NULL
.	NULL

Results	NULL
The	NULL
effects	NULL
of	NULL
inhibitory	NULL
and	NULL
active	NULL
MAPKK-1	NULL
mutants	NULL
on	NULL
NFAT	NULL
induction	NULL
Activation	NULL
of	NULL
p2lras	NULL
in	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
prevented	NULL
by	NULL
expression	NULL
of	NULL
an	NULL
inhibitory	NULL
mutant	NULL
of	NULL
p2lras	NULL
,	NULL
Nl7Ras	NULL
(	NULL
Izquierdo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
N17Ras	NULL
in	NULL
T	NULL
cells	NULL
also	NULL
suppresses	NULL
TCR	NULL
activation	NULL
of	NULL
the	NULL
MAP	NULL
kinases	NULL
ERK-1	NULL
3924	NULL
and	NULL
-2	NULL
,	NULL
which	NULL
correlates	NULL
with	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
N17Ras	NULL
on	NULL
TCR	NULL
activation	NULL
of	NULL
NFAT	NULL
(	NULL
Izquierdo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Woodrow	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993b	NULL
)	NULL
.	NULL

The	NULL
MAP	NULL
kinases	NULL
ERK-1	NULL
and	NULL
-2	NULL
are	NULL
activated	NULL
by	NULL
a	NULL
kinase	NULL
(	NULL
MAPKK	NULL
)	NULL
that	NULL
phosphoryl-ates	NULL
and	NULL
stimulates	NULL
the	NULL
ERK-1	NULL
and	NULL
-2	NULL
kinases	NULL
directly	NULL
.	NULL

MAPKK	NULL
is	NULL
activated	NULL
by	NULL
protein	NULL
phosphorylation	NULL
,	NULL
and	NULL
mutation	NULL
of	NULL
phosphorylation	NULL
sites	NULL
at	NULL
position	NULL
217	NULL
and/or	NULL
221	NULL
on	NULL
MAPKK-1	NULL
from	NULL
serine	NULL
to	NULL
alanine	NULL
generates	NULL
an	NULL
inhibitory	NULL
molecule	NULL
that	NULL
can	NULL
suppress	NULL
growth	NULL
factor-mediated	NULL
activation	NULL
of	NULL
the	NULL
ERK	NULL
kinase	NULL
cascade	NULL
(	NULL
Cowley	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
in	NULL
initial	NULL
experiments	NULL
to	NULL
explore	NULL
whether	NULL
regulation	NULL
of	NULL
ERKs	NULL
explains	NULL
p2lras	NULL
control	NULL
of	NULL
NFAT	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
inhibitory	NULL
mutant	NULL
of	NULL
MAPKK	NULL
221A	NULL
(	NULL
DN	NULL
MAPKK	NULL
)	NULL
on	NULL
TCR	NULL
regulation	NULL
of	NULL
NFAT	NULL
were	NULL
analysed	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT	NULL
,	NULL
we	NULL
employed	NULL
transient	NULL
transfection	NULL
protocols	NULL
and	NULL
quantitation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
whose	NULL
activity	NULL
is	NULL
regulated	NULL
by	NULL
an	NULL
enhancer	NULL
corresponding	NULL
to	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
1A	NULL
show	NULL
that	NULL
this	NULL
NFAT	NULL
reporter	NULL
gene	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
but	NULL
is	NULL
induced	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
the	NULL
antibody	NULL
UCHT-1	NULL
that	NULL
triggers	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
.	NULL

TCR	NULL
induction	NULL
of	NULL
NFAT	NULL
can	NULL
be	NULL
mimicked	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
stimuli	NULL
that	NULL
activate	NULL
PKC	NULL
and	NULL
elevate	NULL
intracellular	NULL
calcium	NULL
levels	NULL
such	NULL
as	NULL
phorbol	NULL
esters	NULL
and	NULL
calcium	NULL
iono-phores	NULL
.	NULL

PKC	NULL
and	NULL
p21ras	NULL
independently	NULL
induce	NULL
NFAT	NULL
and	NULL
similarly	NULL
independently	NULL
activate	NULL
ERK-2	NULL
(	NULL
Izquierdo	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Williams	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

There	NULL
is	NULL
thus	NULL
the	NULL
possibility	NULL
that	NULL
PKC	NULL
and	NULL
Ras	NULL
signals	NULL
for	NULL
NFAT	NULL
induction	NULL
converge	NULL
at	NULL
the	NULL
level	NULL
of	NULL
the	NULL
MAP	NULL
kinases	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
1A	NULL
show	NULL
that	NULL
the	NULL
phorbol	NULL
ester	NULL
phorbol	NULL
12,13	NULL
dibutyrate	NULL
(	NULL
Pdbu	NULL
)	NULL
has	NULL
no	NULL
stimulatory	NULL
effect	NULL
on	NULL
NFAT	NULL
when	NULL
used	NULL
as	NULL
a	NULL
single	NULL
stimulus	NULL
,	NULL
and	NULL
the	NULL
calcium	NULL
ionophore	NULL
ionomycin	NULL
has	NULL
only	NULL
a	NULL
weak	NULL
inductive	NULL
effect	NULL
on	NULL
NFAT	NULL
.	NULL

However	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
calcium	NULL
ionophore	NULL
and	NULL
Pdbu	NULL
synergizes	NULL
to	NULL
give	NULL
maximal	NULL
NFAT	NULL
activity	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
inhibitory	NULL
MAPKK-1	NULL
mutant	NULL
in	NULL
T	NULL
cells	NULL
inhibits	NULL
TCR	NULL
induction	NULL
of	NULL
NFAT	NULL
and	NULL
also	NULL
suppresses	NULL
Pdbu	NULL
and	NULL
ionomycin	NULL
induction	NULL
of	NULL
NFAT	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

In	NULL
four	NULL
experiments	NULL
,	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
the	NULL
dominant	NULL
negative	NULL
MAPKK	NULL
mutant	NULL
on	NULL
the	NULL
TCR/NFAT	NULL
response	NULL
ranged	NULL
from	NULL
77	NULL
to	NULL
50	NULL
%	NULL
,	NULL
whereas	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
this	NULL
mutant	NULL
on	NULL
Pdbu	NULL
plus	NULL
ionomycin	NULL
responses	NULL
ranged	NULL
from	NULL
30	NULL
to	NULL
40	NULL
%	NULL
.	NULL

To	NULL
monitor	NULL
ERK	NULL
activation	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
dominant	NULL
negative	NULL
MAPKK-1	NULL
mutant	NULL
,	NULL
the	NULL
inhibitory	NULL
mutant	NULL
was	NULL
co-expressed	NULL
in	NULL
T	NULL
cells	NULL
with	NULL
ERK-2tag	NULL
,	NULL
an	NULL
epitope-tagged	NULL
ERK-2	NULL
construct	NULL
.	NULL

Activated	NULL
ERK-2	NULL
is	NULL
phosphorylated	NULL
and	NULL
,	NULL
as	NULL
we	NULL
have	NULL
shown	NULL
previously	NULL
,	NULL
activated	NULL
ERK-2tag	NULL
isolated	NULL
from	NULL
Pdbu-	NULL
or	NULL
TCR-activated	NULL
T	NULL
cells	NULL
has	NULL
reduced	NULL
electrophoretic	NULL
mobility	NULL
in	NULL
SDS-PAGE	NULL
gels	NULL
as	NULL
compared	NULL
with	NULL
ERK-2tag	NULL
isolated	NULL
from	NULL
quiescent	NULL
cells	NULL
(	NULL
Izquierdo	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1994a	NULL
,	NULL
b	NULL
)	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
ERK-2tag	NULL
can	NULL
be	NULL
monitored	NULL
sensitively	NULL
by	NULL
analysis	NULL
of	NULL
its	NULL
electrophoretic	NULL
mobility	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
1B	NULL
show	NULL
that	NULL
co-transfecting	NULL
the	NULL
dominant	NULL
negative	NULL
MAPKK-1	NULL
mutant	NULL
with	NULL
ERK-2tag	NULL
prevents	NULL
ERK-2tag	NULL
phosphorylation	NULL
as	NULL
induced	NULL
by	NULL
either	NULL
TCR	NULL
or	NULL
phorbol	NULL
ester	NULL
.	NULL

In	NULL
further	NULL
experiments	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
consequences	NULL
of	NULL
expressing	NULL
a	NULL
constitutively	NULL
activated	NULL
MAPKK-1	NULL
mutant	NULL
on	NULL
NFAT	NULL
induction	NULL
.	NULL

Mutation	NULL
of	NULL
residues	NULL
217	NULL
and	NULL
221	NULL
on	NULL
MAPKK-1	NULL
from	NULL
serine	NULL
to	NULL
glutamic	NULL
acid	NULL
generates	NULL
a	NULL
constitutively	NULL
active	NULL
enzyme	NULL
,	NULL
MAPKK-1	NULL
217E/221E	NULL
(	NULL
MAPKK*	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
this	NULL
constitutively	NULL
active	NULL
BB	NULL
DN	NULL
MAPKK	NULL
NFAT	NULL
regulation	NULL
in	NULL
T	NULL
cells	NULL
NFATCAT|	NULL
[	NULL
}	NULL
none	NULL
W	NULL
ionomycin	NULL
veHt	NULL
conversion	NULL
)	NULL
NFAT	NULL
CAT	NULL
activity	NULL
(	NULL
control	NULL
MAPKK	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
an	NULL
inhibitory	NULL
MAPKK	NULL
mutant	NULL
on	NULL
NFAT	NULL
induction	NULL
.	NULL

(	NULL
A	NULL
)	NULL
10	NULL
``	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
by	NULL
electroporation	NULL
with	NULL
the	NULL
NFATCAT	NULL
reporter	NULL
construct	NULL
(	NULL
15	NULL
ug	NULL
)	NULL
and	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
the	NULL
plasmid	NULL
encoding	NULL
the	NULL
dominant	NULL
negative	NULL
MAPKK-1	NULL
mutant	NULL
(	NULL
20	NULL
ug	NULL
of	NULL
pEXV	NULL
;	NULL
,	NULL
MAPKK	NULL
221A	NULL
,	NULL
DN	NULL
MAPKK	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

At	NULL
6	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

transfected	NULL
cells	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
.	NULL

or	NULL
stimulated	NULL
with	NULL
UCHT-1	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
.	NULL

Pdbu	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
.	NULL

ionomycin	NULL
(	NULL
0.5	NULL
ug/ml	NULL
)	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
Pdbu	NULL
and	NULL
ionomycin	NULL
for	NULL
16	NULL
h	NULL
before	NULL
extracts	NULL
were	NULL
made	NULL
.	NULL

and	NULL
CAT	NULL
reporter	NULL
activity	NULL
was	NULL
assessed	NULL
.	NULL

Data	NULL
show	NULL
the	NULL
percentage	NULL
conversion	NULL
of	NULL
chloramphenicol	NULL
into	NULL
the	NULL
acetylated	NULL
product	NULL
.	NULL

Results	NULL
from	NULL
one	NULL
experiment	NULL
representative	NULL
of	NULL
four	NULL
are	NULL
presented	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
pEF-BOS	NULL
ERK-2tag	NULL
construct	NULL
(	NULL
18	NULL
ug	NULL
)	NULL
together	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
with	NULL
the	NULL
inhibitory	NULL
MAPKK-1	NULL
mutant	NULL
(	NULL
20	NULL
ug	NULL
of	NULL
pEXV	NULL
;	NULL
MAPKK	NULL
221A	NULL
)	NULL
.	NULL

At	NULL
16	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
UCHT-1	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
or	NULL
Pdbu	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Total	NULL
cellular	NULL
extracts	NULL
were	NULL
made	NULL
and	NULL
run	NULL
on	NULL
SDS-PAGE	NULL
(	NULL
15	NULL
%	NULL
acrylamide-0.075	NULL
%	NULL
bisacrylamide	NULL
)	NULL
.	NULL

Data	NULL
show	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
ERK-2tag	NULL
with	NULL
the	NULL
9E10	NULL
antibody	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
NFAT-CAT	NULL
(	NULL
15	NULL
ug	NULL
)	NULL
reporter	NULL
construct	NULL
and	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
the	NULL
constitutively	NULL
active	NULL
Ras	NULL
mutant	NULL
(	NULL
15	NULL
ug	NULL
of	NULL
pEXV	NULL
;	NULL
v-Ha-ras	NULL
.	NULL

Ras*	NULL
)	NULL
or	NULL
constitutively	NULL
active	NULL
MAPKK-1	NULL
mutant	NULL
(	NULL
15	NULL
ug	NULL
of	NULL
pEXV	NULL
;	NULL
,	NULL
MAPKK	NULL
217E/221E	NULL
.	NULL

MAPKK*	NULL
)	NULL
.	NULL

After	NULL
6	NULL
h.	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
Pdbu	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
.	NULL

All	NULL
sets	NULL
of	NULL
transfected	NULL
cells	NULL
were	NULL
then	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
(	NULL
0.5	NULL
ug/ml	NULL
!	NULL
)	NULL

or	NULL
UCHT-1	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
.	NULL

CAT	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Data	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
percentage	NULL
conversion	NULL
of	NULL
chloramphenicol	NULL
into	NULL
the	NULL
acetylated	NULL
product	NULL
.	NULL

Results	NULL
from	NULL
one	NULL
experiment	NULL
representative	NULL
of	NULL
five	NULL
are	NULL
presented	NULL
.	NULL

MAPKK-1	NULL
will	NULL
activate	NULL
the	NULL
MAP	NULL
kinases	NULL
ERK-1	NULL
and	NULL
-2	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
substitute	NULL
for	NULL
activated	NULL
p2lras	NULL
in	NULL
many	NULL
cellular	NULL
responses	NULL
in	NULL
fibroblasts	NULL
and	NULL
neuronal	NULL
cells	NULL
(	NULL
Cowley	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
1C	NULL
are	NULL
representative	NULL
of	NULL
five	NULL
similar	NULL
experiments	NULL
and	NULL
show	NULL
that	NULL
NFAT	NULL
responses	NULL
were	NULL
only	NULL
marginally	NULL
induced	NULL
by	NULL
the	NULL
activated	NULL
MAPKK-1	NULL
mutant	NULL
in	NULL
combination	NULL
with	NULL
ionomycin	NULL
.	NULL

No	NULL
further	NULL
induction	NULL
of	NULL
the	NULL
NFAT-CAT	NULL
reporter	NULL
construct	NULL
could	NULL
be	NULL
seen	NULL
by	NULL
increasing	NULL
or	NULL
decreasing	NULL
the	NULL
amount	NULL
of	NULL
activated	NULL
MAPKK-1	NULL
DNA	NULL
transfected	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
constitutively	NULL
active	NULL
Ras	NULL
mutant	NULL
,	NULL
v-Ha-ras	NULL
,	NULL
which	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
NFAT	NULL
alone	NULL
,	NULL
synergizes	NULL
strongly	NULL
with	NULL
ionomycin	NULL
for	NULL
NFAT	NULL
induction	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
1C	NULL
thus	NULL
show	NULL
that	NULL
the	NULL
activated	NULL
MAPKK-1	NULL
mutant	NULL
does	NULL
not	NULL
mimic	NULL
activated	NULL
p21ras	NULL
for	NULL
NFAT	NULL
induction	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
the	NULL
failure	NULL
of	NULL
the	NULL
active	NULL
MAPKK-1	NULL
217E/	NULL
221E	NULL
mutant	NULL
to	NULL
regulate	NULL
NFAT	NULL
in	NULL
T	NULL
cells	NULL
did	NULL
not	NULL
reflect	NULL
the	NULL
inability	NULL
of	NULL
MAPKK-1	NULL
to	NULL
stimulate	NULL
the	NULL
ERKs	NULL
,	NULL
experiments	NULL
to	NULL
monitor	NULL
ERK-2	NULL
activity	NULL
in	NULL
cells	NULL
expressing	NULL
the	NULL
activated	NULL
MAPKK-1	NULL
mutant	NULL
were	NULL
performed	NULL
.	NULL

In	NULL
initial	NULL
experiments	NULL
,	NULL
the	NULL
activated	NULL
MAPKK-1	NULL
mutant	NULL
was	NULL
co-expressed	NULL
in	NULL
T	NULL
cells	NULL
with	NULL
ERK-2tag	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
2A	NULL
show	NULL
that	NULL
ERK-2tag	NULL
isolated	NULL
from	NULL
T	NULL
cells	NULL
co-transfected	NULL
with	NULL
activated	NULL
MAPKK-1	NULL
mutant	NULL
has	NULL
a	NULL
reduced	NULL
mobility	NULL
in	NULL
SDS-PAGE	NULL
similarly	NULL
to	NULL
the	NULL
ERK-2	NULL
isolated	NULL
from	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
this	NULL
mobility	NULL
shift	NULL
of	NULL
ERK-2tag	NULL
correlates	NULL
with	NULL
activation	NULL
of	NULL
the	NULL
enzyme	NULL
and	NULL
to	NULL
demonstrate	NULL
that	NULL
the	NULL
activated	NULL
MAPKK-1	NULL
could	NULL
stimulate	NULL
ERK-2	NULL
activity	NULL
,	NULL
kinase	NULL
assays	NULL
using	NULL
myelin	NULL
basic	NULL
protein	NULL
(	NULL
MBP	NULL
)	NULL
as	NULL
a	NULL
substrate	NULL
were	NULL
carried	NULL
out	NULL
on	NULL
ERK-2tag	NULL
immunoprecipitates	NULL
isolated	NULL
from	NULL
activated	NULL
MAPKK-1	NULL
or	NULL
control	NULL
transfected	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
used	NULL
this	NULL
system	NULL
previously	NULL
to	NULL
demonstrate	NULL
that	NULL
expression	NULL
of	NULL
activated	NULL
p21lras	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
sufficient	NULL
to	NULL
stimulate	NULL
ERK-2	NULL
kinase	NULL
activity	NULL
(	NULL
Izquierdo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

TCR	NULL
induction	NULL
of	NULL
ERK-2	NULL
is	NULL
transient	NULL
and	NULL
peaks	NULL
at	NULL
10-15	NULL
min	NULL
post-stimulation	NULL
.	NULL

In	NULL
the	NULL
experiment	NULL
presented	NULL
in	NULL
Figure	NULL
2B	NULL
,	NULL
it	NULL
is	NULL
this	NULL
peak	NULL
TCR	NULL
response	NULL
that	NULL
is	NULL
shown	NULL
,	NULL
whereas	NULL
in	NULL
the	NULL
transient	NULL
transfection	NULL
experiments	NULL
the	NULL
sustained	NULL
effects	NULL
of	NULL
either	NULL
activated	NULL
p2Ilras	NULL
or	NULL
MAPKK-1	NULL
mutants	NULL
on	NULL
ERK-2	NULL
are	NULL
monitored	NULL
.	NULL

Expression	NULL
of	NULL
activated	NULL
MAPKK-1	NULL
mutant	NULL
induced	NULL
an	NULL
~5-fold	NULL
increase	NULL
in	NULL
ERK-2	NULL
kinase	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
activated	NULL
p21ras	NULL
induction	NULL
of	NULL
ERK-2	NULL
activity	NULL
is	NULL
50	NULL
%	NULL
of	NULL
the	NULL
maximal	NULL
response	NULL
induced	NULL
by	NULL
the	NULL
TCR	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
our	NULL
previous	NULL
quantitation	NULL
of	NULL
ERK-2	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
expressing	NULL
activated	NULL
p21ras	NULL
(	NULL
Izquierdo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
ERK-2	NULL
activity	NULL
in	NULL
cells	NULL
expressing	NULL
activated	NULL
MAPKK-1	NULL
mutant	NULL
was	NULL
to	NULL
a	NULL
level	NULL
which	NULL
is	NULL
equivalent	NULL
to	NULL
the	NULL
effects	NULL
of	NULL
activated	NULL
p21ras	NULL
on	NULL
ERK-2	NULL
activity	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

The	NULL
effector	NULL
function	NULL
of	NULL
the	NULL
transfected	NULL
activated	NULL
MAPKK-1	NULL
mutant	NULL
on	NULL
the	NULL
endogenous	NULL
ERK	NULL
in	NULL
Jurkat	NULL
cells	NULL
was	NULL
also	NULL
examined	NULL
by	NULL
assessing	NULL
its	NULL
ability	NULL
to	NULL
regulate	NULL
phosphorylation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Elk-1	NULL
,	NULL
which	NULL
is	NULL
a	NULL
cellular	NULL
substrate	NULL
for	NULL
ERK-2	NULL
(	NULL
Marais	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Elk-1	NULL
is	NULL
one	NULL
of	NULL
a	NULL
family	NULL
of	NULL
proteins	NULL
that	NULL
can	NULL
form	NULL
a	NULL
ternary	NULL
complex	NULL
with	NULL
the	NULL
transcriptional	NULL
activator	NULL
SRF	NULL
and	NULL
thus	NULL
can	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
regulation	NULL
of	NULL
c-fos	NULL
gene	NULL
expression	NULL
3925	NULL
E.Genot	NULL
et	NULL
al	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
.	NULL

The	NULL
activated	NULL
MAPKK	NULL
mutant	NULL
is	NULL
able	NULL
to	NULL
activate	NULL
ERK	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
pEF-BOS	NULL
ERK-2tag	NULL
construct	NULL
(	NULL
12.5	NULL
ug	NULL
)	NULL
together	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
,	NULL
or	NULL
with	NULL
the	NULL
activated	NULL
MAPKK-1	NULL
mutant	NULL
(	NULL
12.5	NULL
ug	NULL
of	NULL
pEXV	NULL
;	NULL
,	NULL
MAPKK	NULL
217E/221E	NULL
)	NULL
or	NULL
the	NULL
wild-type	NULL
MAPKK-1	NULL
(	NULL
12.5	NULL
ug	NULL
pEXV	NULL
;	NULL
MAPKK	NULL
wt	NULL
)	NULL
.	NULL

At	NULL
16	NULL
h	NULL
post-transfection	NULL
,	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
Pdbu	NULL
50	NULL
ng/ml	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Total	NULL
cellular	NULL
extracts	NULL
were	NULL
made	NULL
and	NULL
run	NULL
on	NULL
SDS-PAGE	NULL
.	NULL

Data	NULL
show	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
ERK-2tag	NULL
with	NULL
the	NULL
9E10	NULL
antibody	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
pEF	NULL
BOS	NULL
ERK-2tag	NULL
construct	NULL
(	NULL
15	NULL
ug	NULL
)	NULL
together	NULL
with	NULL
25	NULL
ug	NULL
of	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
with	NULL
the	NULL
activated	NULL
Ras	NULL
(	NULL
25	NULL
ug	NULL
of	NULL
pEXV	NULL
;	NULL
v-Ha-ras	NULL
)	NULL
or	NULL
MAPKK-1	NULL
(	NULL
25	NULL
ug	NULL
of	NULL
pEXV	NULL
;	NULL
MAPKK	NULL
217E/221E	NULL
)	NULL
mutants	NULL
.	NULL

At	NULL
16	NULL
h	NULL
post-transfection	NULL
,	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
UCHT-1	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
,	NULL
the	NULL
ERK-2tag	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
the	NULL
9E10	NULL
antibody	NULL
and	NULL
kinase	NULL
activity	NULL
was	NULL
assessed	NULL
in	NULL
a	NULL
kinase	NULL
assay	NULL
using	NULL
MBP	NULL
as	NULL
substrate	NULL
.	NULL

Radioactivity	NULL
incorporated	NULL
into	NULL
MBP	NULL
was	NULL
quantified	NULL
with	NULL
the	NULL
phosphoimager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Data	NULL
show	NULL
the	NULL
MBP	NULL
kinase	NULL
activity	NULL
in	NULL
ERK-2tag	NULL
precipitates	NULL
presented	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
maximal	NULL
response	NULL
obtained	NULL
by	NULL
TCR	NULL
stimulation	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
the	NULL
plasmid	NULL
encoding	NULL
the	NULL
fusion	NULL
protein	NULL
,	NULL
pEF	NULL
N	NULL
Lex-Elk-1C	NULL
,	NULL
together	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
with	NULL
the	NULL
activated	NULL
Ras	NULL
(	NULL
20	NULL
ug	NULL
of	NULL
pEXV	NULL
;	NULL
v-Ha-ras	NULL
)	NULL
or	NULL
MAPKK-1	NULL
(	NULL
20	NULL
ug	NULL
of	NULL
pEXV	NULL
;	NULL
,	NULL
MAPKK	NULL
217E/221E	NULL
)	NULL
mutants	NULL
.	NULL

At	NULL
16	NULL
h	NULL
post-transfection	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
and	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
UCHT-1	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
or	NULL
Pdbu	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Total	NULL
cell	NULL
extracts	NULL
were	NULL
made	NULL
and	NULL
run	NULL
on	NULL
SDS-PAGE	NULL
.	NULL

Data	NULL
show	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
Lex	NULL
A-Elk-1C	NULL
with	NULL
LexA	NULL
antibodies	NULL
.	NULL

(	NULL
Hill	NULL
and	NULL
Treisman	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
that	NULL
activators	NULL
of	NULL
the	NULL
ERK	NULL
kinase	NULL
cascade	NULL
can	NULL
induce	NULL
phosphorylation	NULL
of	NULL
the	NULL
Elk-1	NULL
C-terminus	NULL
and	NULL
potentiate	NULL
Elk-1	NULL
transcriptional	NULL
activity	NULL
(	NULL
Price	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995b	NULL
)	NULL
.	NULL

To	NULL
monitor	NULL
this	NULL
phosphorylation	NULL
,	NULL
a	NULL
fusion	NULL
protein	NULL
comprising	NULL
the	NULL
C-terminus	NULL
of	NULL
Elk-1	NULL
linked	NULL
to	NULL
the	NULL
LexA	NULL
repressor	NULL
(	NULL
LexA-Elk-1C	NULL
)	NULL
was	NULL
co-transfected	NULL
into	NULL
T	NULL
cells	NULL
with	NULL
activated	NULL
p2lras	NULL
or	NULL
MAPKK-L	NULL
mutants	NULL
.	NULL

The	NULL
phosphorylation	NULL
of	NULL
LexA-Elk-1C	NULL
reduces	NULL
its	NULL
electrophoretic	NULL
mobility	NULL
in	NULL
SDS-PAGE	NULL
gels	NULL
.	NULL

Accordingly	NULL
,	NULL
the	NULL
data	NULL
in	NULL
Figure	NULL
2C	NULL
show	NULL
the	NULL
reduced	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
LexA-Elk-1	NULL
in	NULL
Pdbu-	NULL
or	NULL
TCR-activated	NULL
cells	NULL
compared	NULL
with	NULL
control	NULL
unstimulated	NULL
cells	NULL
.	NULL

LexA-Elk-1C	NULL
isolated	NULL
from	NULL
T	NULL
cells	NULL
expressing	NULL
either	NULL
activated	NULL
p21ras	NULL
or	NULL
activated	NULL
MAPKK-1	NULL
mutant	NULL
has	NULL
a	NULL
similar	NULL
reduced	NULL
electrophoretic	NULL
mobility	NULL
(	NULL
Figure	NULL
2C	NULL
)	NULL
.	NULL

The	NULL
activated	NULL
MAPKK	NULL
and	NULL
activated	NULL
p21ras	NULL
had	NULL
equivalent	NULL
stimulatory	NULL
effects	NULL
on	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
Elk-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
the	NULL
data	NULL
in	NULL
Figures	NULL
1	NULL
and	NULL
2	NULL
show	NULL
that	NULL
expression	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
mutant	NULL
of	NULL
MAPKK-1	NULL
suppresses	NULL
TCR	NULL
induction	NULL
of	NULL
NFAT	NULL
.	NULL

The	NULL
data	NULL
demonstrate	NULL
also	NULL
that	NULL
expression	NULL
of	NULL
an	NULL
activated	NULL
MAPKK-1	NULL
mutant	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
sufficient	NULL
for	NULL
ERK-2	NULL
activation	NULL
and	NULL
sufficient	NULL
for	NULL
phosphorylation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Elk-1	NULL
.	NULL

However	NULL
,	NULL
expression	NULL
of	NULL
a	NULL
constitutively	NULL
active	NULL
MAPKK-1	NULL
mutant	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
substitute	NULL
for	NULL
p2	NULL
Iras	NULL
for	NULL
NFAT	NULL
induction	NULL
.	NULL

Accordingly	NULL
,	NULL
to	NULL
explain	NULL
p2lras	NULL
regulation	NULL
of	NULL
NFAT	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
necessary	NULL
to	NULL
invoke	NULL
the	NULL
existence	NULL
of	NULL
alternative	NULL
Ras	NULL
effector	NULL
pathways	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
inhibitory	NULL
and	NULL
activated	NULL
mutants	NULL
of	NULL
Rac-1	NULL
on	NULL
NFAT	NULL
induction	NULL
The	NULL
Ras-related	NULL
GTPase	NULL
Rac-1	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
a	NULL
downstream	NULL
effector	NULL
of	NULL
p2	NULL
1ras	NULL
in	NULL
fibroblast	NULL
transformation	NULL
3926	NULL
(	NULL
Qiu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
Rac-1	NULL
in	NULL
NFAT	NULL
regulation	NULL
in	NULL
T	NULL
cells	NULL
was	NULL
explored	NULL
by	NULL
monitoring	NULL
the	NULL
effects	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
Rac-1	NULL
mutant	NULL
,	NULL
Nl7Rac	NULL
,	NULL
and	NULL
a	NULL
constitutively	NULL
active	NULL
Rac-1	NULL
mutant	NULL
,	NULL
V12Rac	NULL
(	NULL
Rac*	NULL
)	NULL
(	NULL
Nobes	NULL
and	NULL
Hall	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
3A	NULL
show	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
dominant	NULL
negative	NULL
N17Rac	NULL
molecule	NULL
inhibits	NULL
NFAT	NULL
induction	NULL
by	NULL
the	NULL
TCR	NULL
and	NULL
also	NULL
,	NULL
although	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
suppresses	NULL
the	NULL
NFAT	NULL
response	NULL
induced	NULL
by	NULL
phorbol	NULL
ester	NULL
and	NULL
calcium	NULL
ionophore	NULL
.	NULL

In	NULL
an	NULL
experiment	NULL
that	NULL
investigated	NULL
the	NULL
N17Rac	NULL
dose	NULL
dependency	NULL
of	NULL
NFAT	NULL
induction	NULL
,	NULL
it	NULL
appeared	NULL
that	NULL
Pdbu	NULL
and	NULL
ionomycin	NULL
induction	NULL
of	NULL
NFAT	NULL
comprised	NULL
an	NULL
Nl7Rac-sensitive	NULL
and	NULL
-insensitive	NULL
component	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
selectivity	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
dominant	NULL
negative	NULL
mutant	NULL
of	NULL
Rac-1	NULL
on	NULL
TCR	NULL
signalling	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
Nl7Rac-1	NULL
on	NULL
TCR	NULL
and	NULL
Pdbu	NULL
activation	NULL
of	NULL
ERK-2	NULL
were	NULL
determined	NULL
.	NULL

Accordingly	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
ERK-2tag	NULL
either	NULL
alone	NULL
or	NULL
together	NULL
with	NULL
N17Rac	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
3C	NULL
show	NULL
that	NULL
TCR	NULL
or	NULL
Pdbu	NULL
stimulation	NULL
or	NULL
transfection	NULL
of	NULL
activated	NULL
p2lras	NULL
induces	NULL
ERK-2	NULL
activation	NULL
while	NULL
expression	NULL
of	NULL
activated	NULL
Rac	NULL
mutant	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
ERK-2	NULL
activity	NULL
.	NULL

Co-expressing	NULL
N17Rac	NULL
in	NULL
these	NULL
cells	NULL
did	NULL
not	NULL
affect	NULL
p21ras	NULL
,	NULL
TCR	NULL
or	NULL
Pdbu	NULL
activation	NULL
of	NULL
ERK-2	NULL
,	NULL
showing	NULL
that	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
N17Rac	NULL
did	NULL
not	NULL
result	NULL
from	NULL
inhibition	NULL
of	NULL
ERK-2	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
.	NULL

To	NULL
explore	NULL
further	NULL
the	NULL
role	NULL
of	NULL
Rac-1	NULL
in	NULL
NFAT	NULL
regulation	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
an	NULL
activated	NULL
Rac-l	NULL
mutant	NULL
(	NULL
V12Rac	NULL
)	NULL
on	NULL
transcription	NULL
factor	NULL
activity	NULL
were	NULL
compared	NULL
with	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
activated	NULL
mutant	NULL
.	NULL

p21lras	NULL
can	NULL
regulate	NULL
the	NULL
transcription	NULL
factor	NULL
AP-1	NULL
activity	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cells	NULL
including	NULL
T	NULL
cells	NULL
(	NULL
Rayter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Woodrow	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993b	NULL
)	NULL
.	NULL

To	NULL
compare	NULL
p2lras	NULL
and	NULL
Rac-1	NULL
regulation	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
AP-1	NULL
,	NULL
we	NULL
quantified	NULL
the	NULL
expression	NULL
of	NULL
an	NULL
AP-1-CAT	NULL
reporter	NULL
gene	NULL
.	NULL

The	NULL
AP-1	NULL
reporter	NULL
gene	NULL
can	NULL
be	NULL
induced	NULL
NFAT	NULL
CAT	NULL
activity	NULL
(	NULL
fold	NULL
increase	NULL
of	NULL
the	NULL
control	NULL
response	NULL
)	NULL
Lonomycin	NULL
Pdbu	NULL
+	NULL
NFAT	NULL
regulation	NULL
in	NULL
T	NULL
cells	NULL
&	NULL
NFAT	NULL
CAT	NULL
-o-	NULL
_	NULL
UCHTI	NULL
-	NULL
&	NULL
Pdbu+	NULL
ionomycin	NULL
NFATCAT	NULL
activity	NULL
(	NULL
%	NULL
maximum	NULL
response	NULL
)	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
an	NULL
inhibitory	NULL
Rac	NULL
mutant	NULL
on	NULL
NFAT	NULL
induction	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
NFAT-CAT	NULL
reporter	NULL
construct	NULL
(	NULL
12	NULL
ug	NULL
)	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
the	NULL
dominant	NULL
negative	NULL
Rac	NULL
mutant-containing	NULL
plasmid	NULL
(	NULL
5	NULL
ug	NULL
of	NULL
pcDNA	NULL
N17Rac	NULL
)	NULL
.	NULL

At	NULL
6	NULL
h	NULL
post-transfection	NULL
.	NULL

cells	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
UCHT-1	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
Pdbu	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
0.5	NULL
ug/ml	NULL
)	NULL
for	NULL
16	NULL
h	NULL
before	NULL
extracts	NULL
were	NULL
made	NULL
.	NULL

and	NULL
CAT	NULL
reporter	NULL
activity	NULL
was	NULL
assessed	NULL
.	NULL

Data	NULL
show	NULL
fold	NULL
induction	NULL
of	NULL
NFAT-CAT	NULL
activity	NULL
.	NULL

Results	NULL
from	NULL
one	NULL
experiment	NULL
representative	NULL
of	NULL
five	NULL
are	NULL
presented	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
NFAT-CAT	NULL
reporter	NULL
construct	NULL
(	NULL
12	NULL
pg	NULL
)	NULL
and	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
different	NULL
concentrations	NULL
of	NULL
the	NULL
inhibitory	NULL
Rac	NULL
mutant	NULL
(	NULL
pcDNA1	NULL
N17Rac	NULL
)	NULL
.	NULL

and	NULL
the	NULL
experiment	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Data	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
maximum	NULL
NFAT-CAT	NULL
induction	NULL
obtained	NULL
with	NULL
UCHT-1	NULL
stimulation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
inhibitory	NULL
Rac	NULL
mutant	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
ERK-2tag	NULL
construct	NULL
(	NULL
18	NULL
ug	NULL
)	NULL
together	NULL
with	NULL
8	NULL
ug	NULL
of	NULL
the	NULL
empty	NULL
vector	NULL
.	NULL

or	NULL
plasmids	NULL
encoding	NULL
active	NULL
Ras	NULL
(	NULL
8	NULL
ug	NULL
of	NULL
pEF-BOS	NULL
v-Ha-ras	NULL
)	NULL
or	NULL
the	NULL
active	NULL
Rac	NULL
(	NULL
8	NULL
ug	NULL
of	NULL
pEFplink	NULL
V12Rac	NULL
.	NULL

Rac*	NULL
)	NULL
mutants	NULL
.	NULL

in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
inhibitory	NULL
Rac	NULL
mutant	NULL
(	NULL
pcDNA	NULL
N17Rac	NULL
)	NULL
.	NULL

At	NULL
16	NULL
h	NULL
post-transfection	NULL
.	NULL

cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
with	NULL
the	NULL
plasmid	NULL
encoding	NULL
the	NULL
inhibitory	NULL
mutant	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
UCHT-1	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
or	NULL
Pdbu	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Total	NULL
cellular	NULL
extracts	NULL
were	NULL
made	NULL
and	NULL
run	NULL
on	NULL
SDS-PAGE	NULL
.	NULL

The	NULL
data	NULL
show	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
ERK-2tag	NULL
with	NULL
the	NULL
9E10	NULL
antibody	NULL
.	NULL

by	NULL
Pdbu	NULL
,	NULL
TCR	NULL
triggering	NULL
with	NULL
UCHT1l	NULL
antibodies	NULL
and	NULL
constitutively	NULL
active	NULL
p2lras	NULL
protein	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

AP-1	NULL
activity	NULL
is	NULL
also	NULL
induced	NULL
by	NULL
the	NULL
activated	NULL
Rac-1	NULL
mutant	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

Further	NULL
experiments	NULL
demonstrate	NULL
that	NULL
TCR	NULL
and	NULL
Pdbu	NULL
induction	NULL
of	NULL
AP-1	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
are	NULL
prevented	NULL
by	NULL
expression	NULL
of	NULL
the	NULL
dominant	NULL
negative	NULL
Rac-1	NULL
mutant	NULL
N1l7Rac	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
Rac-1	NULL
activity	NULL
is	NULL
essential	NULL
for	NULL
TCR	NULL
and	NULL
Ras	NULL
regulation	NULL
of	NULL
AP-1	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
expression	NULL
of	NULL
constitutively	NULL
activated	NULL
Rac-1	NULL
is	NULL
sufficient	NULL
to	NULL
stimulate	NULL
levels	NULL
of	NULL
AP-1	NULL
activity	NULL
comparable	NULL
with	NULL
that	NULL
seen	NULL
in	NULL
cells	NULL
expressing	NULL
activated	NULL
p2lras	NULL
mutants	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

To	NULL
compare	NULL
p21lras	NULL
and	NULL
MAPKK-1	NULL
regulation	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
AP-1	NULL
,	NULL
we	NULL
quantified	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
AP-I-CAT	NULL
reporter	NULL
gene	NULL
in	NULL
cells	NULL
expressing	NULL
either	NULL
constitutively	NULL
active	NULL
p2lras	NULL
protein	NULL
or	NULL
activated	NULL
MAPKK-1	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
4C	NULL
show	NULL
that	NULL
AP-1-CAT	NULL
is	NULL
not	NULL
induced	NULL
by	NULL
expression	NULL
of	NULL
activated	NULL
MAPKK-1	NULL
mutant	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Since	NULL
AP-1	NULL
is	NULL
a	NULL
component	NULL
of	NULL
the	NULL
active	NULL
NFAT	NULL
complex	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
also	NULL
assessed	NULL
the	NULL
effects	NULL
of	NULL
activated	NULL
Rac-1	NULL
on	NULL
NFAT	NULL
responses	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
5A	NULL
show	NULL
that	NULL
activated	NULL
Rac-1	NULL
could	NULL
not	NULL
mimic	NULL
activated	NULL
p2lras	NULL
and	NULL
synergize	NULL
with	NULL
calcium	NULL
signals	NULL
for	NULL
NFAT	NULL
induction	NULL
.	NULL

No	NULL
NFAT	NULL
induction	NULL
could	NULL
be	NULL
seen	NULL
when	NULL
using	NULL
the	NULL
activated	NULL
Rac	NULL
mutant	NULL
,	NULL
in	NULL
conditions	NULL
for	NULL
which	NULL
activated	NULL
Ras	NULL
was	NULL
effective	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
and	NULL
under	NULL
conditions	NULL
where	NULL
activated	NULL
Rac-	NULL
!	NULL

1	NULL
could	NULL
induce	NULL
AP-1	NULL
.	NULL

Given	NULL
that	NULL
neither	NULL
expression	NULL
of	NULL
activated	NULL
MAPKK-1	NULL
nor	NULL
activated	NULL
Rac-l	NULL
substitute	NULL
for	NULL
p21ras	NULL
for	NULL
NFAT	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
possibility	NULL
of	NULL
a	NULL
synergy	NULL
between	NULL
MAPKK-1	NULL
and	NULL
Rac-1	NULL
.	NULL

Data	NULL
presented	NULL
in	NULL
Figure	NULL
5C	NULL
show	NULL
that	NULL
the	NULL
combination	NULL
of	NULL
activated	NULL
Rac-1	NULL
and	NULL
activated	NULL
MAPKK	NULL
could	NULL
not	NULL
synergize	NULL
with	NULL
calcium	NULL
signals	NULL
to	NULL
induce	NULL
NFAT	NULL
.	NULL

No	NULL
further	NULL
induction	NULL
of	NULL
the	NULL
NFAT-CAT	NULL
reporter	NULL
construct	NULL
could	NULL
be	NULL
seen	NULL
when	NULL
transfecting	NULL
different	NULL
ratios	NULL
of	NULL
the	NULL
two	NULL
plasmids	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figures	NULL
1-5	NULL
collectively	NULL
show	NULL
that	NULL
MAPKK-1	NULL
and	NULL
Rac-1	NULL
function	NULL
are	NULL
each	NULL
important	NULL
but	NULL
not	NULL
sufficient	NULL
,	NULL
neither	NULL
alone	NULL
nor	NULL
in	NULL
combination	NULL
,	NULL
for	NULL
TCR	NULL
and	NULL
p2lras	NULL
regulation	NULL
of	NULL
NFAT	NULL
.	NULL

p21ras	NULL
regulation	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
in	NULL
T	NULL
cells	NULL
requires	NULL
Rac-1	NULL
function	NULL
To	NULL
position	NULL
Rac-1	NULL
in	NULL
p2lras	NULL
signalling	NULL
pathways	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
dominant	NULL
negative	NULL
Rac-1	NULL
mutants	NULL
on	NULL
signals	NULL
generated	NULL
by	NULL
the	NULL
constitutively	NULL
active	NULL
p2lras	NULL
mutant	NULL
were	NULL
monitored	NULL
.	NULL

Expression	NULL
of	NULL
N1l7Rac-l	NULL
did	NULL
not	NULL
prevent	NULL
expression	NULL
of	NULL
the	NULL
constitutively	NULL
active	NULL
p21lras	NULL
mutant	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
activated	NULL
Rac-1	NULL
did	NULL
not	NULL
induce	NULL
activation	NULL
of	NULL
ERK-2	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
,	NULL
nor	NULL
did	NULL
expression	NULL
of	NULL
N17Rac	NULL
prevent	NULL
p2lras-	NULL
or	NULL
Pdbu-mediated	NULL
activation	NULL
of	NULL
ERK-2	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
.	NULL

Results	NULL
presented	NULL
in	NULL
Figure	NULL
6A	NULL
show	NULL
that	NULL
expression	NULL
of	NULL
Nl7Rac	NULL
did	NULL
not	NULL
prevent	NULL
p2lras-mediated	NULL
phosphorylation	NULL
of	NULL
Elk-1	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
failure	NULL
of	NULL
the	NULL
dominant	NULL
negative	NULL
Rac-1	NULL
to	NULL
prevent	NULL
p2ras-mediated	NULL
activation	NULL
of	NULL
the	NULL
ERK-2	NULL
pathway	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
.	NULL

Activators	NULL
of	NULL
the	NULL
ERK	NULL
kinase	NULL
cascade	NULL
can	NULL
induce	NULL
transcriptional	NULL
activation	NULL
by	NULL
the	NULL
Elk-1	NULL
C-terminus	NULL
(	NULL
Price	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995b	NULL
;	NULL
Hill	NULL
and	NULL
Treisman	NULL
,	NULL
1995	NULL
)	NULL
To	NULL
monitor	NULL
Elk-1	NULL
transcriptional	NULL
activity	NULL
,	NULL
LexA-Elk-1C	NULL
was	NULL
co-transfected	NULL
into	NULL
T	NULL
cells	NULL
with	NULL
a	NULL
Lex	NULL
A	NULL
operator-controlled	NULL
CAT	NULL
reporter	NULL
3927	NULL
E.Genot	NULL
et	NULL
al	NULL
.	NULL

AP-1	NULL
CAT	NULL
UCHT1	NULL
-*-	NULL
_	NULL
Pdbu	NULL
>	NULL
activi	NULL
AT	NULL
C	NULL
AP-1	NULL
N17Rac	NULL
concentration	NULL
(	NULL
microgram/10	NULL
million	NULL
cells	NULL
AP-1	NULL
CAT	NULL
conversion	NULL
)	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
Rac	NULL
and	NULL
MAPKK	NULL
mutants	NULL
on	NULL
AP-1	NULL
induction	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
AP-1-CAT	NULL
reporter	NULL
construct	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
and	NULL
8	NULL
ug	NULL
of	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
the	NULL
plasmid	NULL
encoding	NULL
the	NULL
constitutively	NULL
active	NULL
Ras	NULL
(	NULL
pEF-BOS	NULL
v-Ha-ras	NULL
)	NULL
or	NULL
active	NULL
Rac	NULL
(	NULL
pEFplinkV12Rac	NULL
)	NULL
mutants	NULL
.	NULL

After	NULL
6	NULL
h	NULL
,	NULL
transfected	NULL
cells	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
UCHT-1	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
or	NULL
Pdbu	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
16	NULL
h	NULL
before	NULL
extracts	NULL
were	NULL
made	NULL
,	NULL
and	NULL
CAT	NULL
reporter	NULL
activity	NULL
was	NULL
assessed	NULL
.	NULL

Data	NULL
are	NULL
presented	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
maximum	NULL
AP-1-CAT	NULL
response	NULL
induced	NULL
by	NULL
Pdbu	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
AP-1-CAT	NULL
reporter	NULL
construct	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
and	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
different	NULL
concentrations	NULL
of	NULL
the	NULL
plasmid	NULL
encoding	NULL
the	NULL
inhibitory	NULL
Rac	NULL
mutant	NULL
(	NULL
pcDNA1	NULL
N17Rac	NULL
)	NULL
,	NULL
and	NULL
the	NULL
experiment	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Data	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
maximum	NULL
response	NULL
obtained	NULL
with	NULL
Pdbu	NULL
stimulation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
inhibitory	NULL
Rac	NULL
mutant	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
AP-1-CAT	NULL
reporter	NULL
construct	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
and	NULL
15	NULL
ug	NULL
of	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
the	NULL
constitutively	NULL
active	NULL
Ras	NULL
mutant	NULL
(	NULL
15	NULL
ug	NULL
of	NULL
pEXV	NULL
;	NULL
v-Ha-ras	NULL
)	NULL
or	NULL
constitutively	NULL
active	NULL
MAPKK-1	NULL
mutant	NULL
(	NULL
15	NULL
ug	NULL
of	NULL
pEXV	NULL
;	NULL
MAPKK	NULL
217E/221E	NULL
)	NULL
.	NULL

At	NULL
6	NULL
h	NULL
post-transfection	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
UCHT-1	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
or	NULL
Pdbu	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
16	NULL
h	NULL
before	NULL
extracts	NULL
were	NULL
made	NULL
,	NULL
and	NULL
CAT	NULL
reporter	NULL
activity	NULL
was	NULL
assessed	NULL
.	NULL

Data	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
conversion	NULL
of	NULL
chloramphenicol	NULL
into	NULL
the	NULL
acetylated	NULL
product	NULL
.	NULL

gene	NULL
(	NULL
LexA-OPtkCAT	NULL
)	NULL
.	NULL

LexA-Elk-1C	NULL
_	NULL
transcription	NULL
activity	NULL
is	NULL
low	NULL
in	NULL
unactivated	NULL
T	NULL
cells	NULL
but	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
co-expression	NULL
of	NULL
a	NULL
constitutively	NULL
active	NULL
p21ras	NULL
,	NULL
v-Ha-Ras	NULL
,	NULL
or	NULL
by	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
Pdbu	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
N17Rac	NULL
did	NULL
not	NULL
suppress	NULL
Pdbu	NULL
or	NULL
v-Ha-ras	NULL
induction	NULL
of	NULL
LexA-Elk-1C	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
the	NULL
same	NULL
experiment	NULL
,	NULL
Nl7Rac	NULL
inhibits	NULL
the	NULL
AP-1	NULL
response	NULL
induced	NULL
by	NULL
the	NULL
constitutively	NULL
active	NULL
p2lras	NULL
(	NULL
Figure	NULL
6C	NULL
)	NULL
and	NULL
also	NULL
prevents	NULL
NFAT	NULL
induction	NULL
induced	NULL
by	NULL
activated	NULL
p2	NULL
1ras	NULL
plus	NULL
calcium	NULL
ionophore	NULL
(	NULL
Figure	NULL
6D	NULL
)	NULL
.	NULL

These	NULL
data	NULL
thus	NULL
indicate	NULL
that	NULL
Rac-1	NULL
function	NULL
is	NULL
required	NULL
for	NULL
p21lras	NULL
induction	NULL
of	NULL
AP-1	NULL
and	NULL
NFAT	NULL
but	NULL
Rac-1	NULL
function	NULL
is	NULL
not	NULL
necessary	NULL
for	NULL
p21lras	NULL
activation	NULL
of	NULL
ERK-2	NULL
and	NULL
Elk-1	NULL
.	NULL

Expression	NULL
of	NULL
activated	NULL
Rac-1	NULL
did	NULL
not	NULL
activate	NULL
ERK-2	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
nor	NULL
was	NULL
Rac-1	NULL
function	NULL
necessary	NULL
for	NULL
TCR-	NULL
and	NULL
p2lras-mediated	NULL
stimulation	NULL
of	NULL
ERK-2	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
it	NULL
has	NULL
been	NULL
described	NULL
that	NULL
Rac-1	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
AP-1	NULL
regulation	NULL
via	NULL
control	NULL
of	NULL
Jun	NULL
kinases	NULL
such	NULL
as	NULL
JNK/SAPK	NULL
.	NULL

Elk-1	NULL
has	NULL
also	NULL
been	NULL
described	NULL
to	NULL
be	NULL
a	NULL
substrate	NULL
for	NULL
the	NULL
JNK/SAPK	NULL
family	NULL
(	NULL
Whitmarsh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Zinck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
and	NULL
to	NULL
explore	NULL
if	NULL
Rac-1	NULL
could	NULL
regulate	NULL
transcription	NULL
factor	NULL
phosphorylation	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
3928	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
activated	NULL
Rac-1	NULL
on	NULL
LexA-Elk-1C	NULL
phosphorylation	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
6A	NULL
show	NULL
that	NULL
expression	NULL
of	NULL
V	NULL
12Rac-1	NULL
in	NULL
T	NULL
cells	NULL
induced	NULL
phosphorylation	NULL
of	NULL
Lex	NULL
A-Elk-1C	NULL
comparable	NULL
with	NULL
that	NULL
induced	NULL
by	NULL
activated	NULL
p2lras	NULL
.	NULL

Rac-1	NULL
function	NULL
is	NULL
not	NULL
required	NULL
for	NULL
p2lras	NULL
induction	NULL
of	NULL
Elk-1	NULL
(	NULL
Figure	NULL
6A	NULL
and	NULL
B	NULL
)	NULL
which	NULL
is	NULL
mediated	NULL
via	NULL
ERK-2	NULL
.	NULL

Nevertheless	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
,	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
Rac-1	NULL
has	NULL
the	NULL
potential	NULL
to	NULL
regulate	NULL
a	NULL
kinase	NULL
cascade	NULL
that	NULL
can	NULL
converge	NULL
with	NULL
the	NULL
ERK-2	NULL
pathway	NULL
on	NULL
the	NULL
transcription	NULL
factor	NULL
Elk-1	NULL
.	NULL

Discussion	NULL
The	NULL
MAP	NULL
kinase	NULL
ERK-2	NULL
has	NULL
been	NULL
proposed	NULL
to	NULL
be	NULL
a	NULL
major	NULL
effector	NULL
of	NULL
the	NULL
p21ras	NULL
signal	NULL
transduction	NULL
pathways	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
systems	NULL
including	NULL
the	NULL
differentiation	NULL
of	NULL
PC12	NULL
cells	NULL
and	NULL
the	NULL
transformation	NULL
of	NULL
fibroblasts	NULL
.	NULL

The	NULL
present	NULL
study	NULL
has	NULL
used	NULL
constitutively	NULL
active	NULL
and	NULL
inhibitory	NULL
mutants	NULL
of	NULL
a	NULL
MAP	NULL
kinase	NULL
kinase	NULL
(	NULL
MAPKK-1	NULL
)	NULL
to	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
this	NULL
pathway	NULL
in	NULL
TCR	NULL
signal	NULL
transduction	NULL
.	NULL

Activated	NULL
mutants	NULL
of	NULL
MAPKK-1	NULL
can	NULL
stimulate	NULL
ERK-2	NULL
kinase	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
can	NULL
also	NULL
induce	NULL
phosphoryl-	NULL
conversion	NULL
)	NULL
NFAT	NULL
CAT	NULL
activity	NULL
(	NULL
%	NULL
d	NULL
NFAT	NULL
CAT	NULL
activity	NULL
-e-	NULL
>	NULL
DNA	NULL
concentration	NULL
(	NULL
microgram/10	NULL
million	NULL
cells	NULL
)	NULL
NFAT	NULL
regulation	NULL
in	NULL
T	NULL
cells	NULL
ol	NULL
ac	NULL
\i\lL\rlr	NULL
(	NULL
)	NULL
control	NULL
M	NULL
Ras	NULL
$	NULL
7	NULL
E	NULL
Ra	NULL
C	NULL
Â£	NULL
~	NULL
RFATCAT	NULL
|	NULL
M	NULL
none	NULL
m	NULL
Z	NULL
10	NULL
-on	NULL
J	NULL
.	NULL

a	NULL
>	NULL
A	NULL
29	NULL
3	NULL
%	NULL
2	NULL
A	NULL
3	NULL
|	NULL
A	NULL
$	NULL
2	NULL
7	NULL
A	NULL
|	NULL
I	NULL
n	NULL
o	NULL
2a	NULL
2a	NULL
a	NULL
aB	NULL
o	NULL
m	NULL
2	NULL
'*	NULL
ntr	NULL
Pdbu	NULL
a	NULL
R	NULL
MAPKKÂ®	NULL
MAPKK	NULL
+RacÂ®	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
activated	NULL
Rac	NULL
and	NULL
Ras	NULL
mutant	NULL
on	NULL
NFAT	NULL
induction	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cells	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
NFAT-CAT	NULL
reporter	NULL
construct	NULL
(	NULL
12	NULL
ug	NULL
)	NULL
and	NULL
8	NULL
ug	NULL
of	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
the	NULL
plasmid	NULL
encoding	NULL
activated	NULL
Ras	NULL
(	NULL
8	NULL
ug	NULL
of	NULL
pEF-BOS	NULL
v-Ha-ras	NULL
)	NULL
or	NULL
activated	NULL
Rac	NULL
(	NULL
8	NULL
ug	NULL
of	NULL
pEFplinkV12Rac	NULL
)	NULL
mutants	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
(	NULL
0.5	NULL
ug/ml	NULL
!	NULL
)	NULL

or	NULL
a	NULL
combination	NULL
of	NULL
Pdbu	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
0.5	NULL
ug/ml	NULL
)	NULL
,	NULL
6	NULL
h	NULL
post-transfection	NULL
and	NULL
for	NULL
16	NULL
h	NULL
before	NULL
extracts	NULL
were	NULL
made	NULL
,	NULL
and	NULL
CAT	NULL
reporter	NULL
activity	NULL
was	NULL
then	NULL
assessed	NULL
.	NULL

Data	NULL
show	NULL
the	NULL
percentage	NULL
conversion	NULL
of	NULL
chloramphenicol	NULL
into	NULL
the	NULL
acetylated	NULL
product	NULL
.	NULL

Results	NULL
from	NULL
one	NULL
experiment	NULL
representative	NULL
of	NULL
four	NULL
are	NULL
presented	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
NFAT-CAT	NULL
reporter	NULL
construct	NULL
(	NULL
12	NULL
ug	NULL
)	NULL
and	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
different	NULL
concentrations	NULL
of	NULL
the	NULL
plasmid	NULL
encoding	NULL
the	NULL
activated	NULL
Ras	NULL
(	NULL
pEF-BOS	NULL
v-Ha-ras	NULL
)	NULL
or	NULL
activated	NULL
Rac	NULL
(	NULL
pEFplinkV12Rac	NULL
)	NULL
mutants	NULL
,	NULL
and	NULL
the	NULL
experiment	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Data	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
conversion	NULL
of	NULL
chloramphenicol	NULL
into	NULL
the	NULL
acetylated	NULL
product	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Plasmids	NULL
encoding	NULL
the	NULL
activated	NULL
Ras	NULL
(	NULL
15	NULL
ug	NULL
of	NULL
pEXV	NULL
;	NULL
v-Ha-ras	NULL
)	NULL
,	NULL
the	NULL
activated	NULL
MAPKK-1	NULL
(	NULL
15	NULL
ug	NULL
pEXV	NULL
;	NULL
MAPKK	NULL
217E/221E	NULL
)	NULL
or	NULL
the	NULL
activated	NULL
Rac	NULL
(	NULL
15	NULL
ug	NULL
of	NULL
pEFplinkV12Rac	NULL
)	NULL
mutants	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
the	NULL
activated	NULL
MAPKK-1	NULL
(	NULL
15	NULL
ug	NULL
of	NULL
pEXV	NULL
;	NULL
,	NULL
MAPKK	NULL
217E/221E	NULL
)	NULL
and	NULL
activated	NULL
Rac-1	NULL
(	NULL
15	NULL
ug	NULL
of	NULL
pEFplinkV12Rac	NULL
)	NULL
mutants	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
NFAT-CAT	NULL
reporter	NULL
construct	NULL
(	NULL
12	NULL
ug	NULL
)	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
Pdbu	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
then	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
(	NULL
0.5	NULL
pg/ml	NULL
)	NULL
or	NULL
UCHT-1	NULL
(	NULL
10	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
16	NULL
h	NULL
before	NULL
extracts	NULL
were	NULL
made	NULL
,	NULL
and	NULL
CAT	NULL
reporter	NULL
activity	NULL
was	NULL
assessed	NULL
.	NULL

Data	NULL
show	NULL
the	NULL
percentage	NULL
conversion	NULL
of	NULL
chloramphenicol	NULL
into	NULL
the	NULL
acetylated	NULL
product	NULL
.	NULL

Results	NULL
from	NULL
one	NULL
experiment	NULL
representative	NULL
of	NULL
four	NULL
are	NULL
presented	NULL
.	NULL

ation	NULL
of	NULL
the	NULL
ternary	NULL
complex	NULL
factor	NULL
Elk-1	NULL
,	NULL
demonstrating	NULL
that	NULL
MAPKK-1	NULL
is	NULL
an	NULL
effector	NULL
molecule	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Elk-1	NULL
in	NULL
T	NULL
cells	NULL
as	NULL
in	NULL
fibroblasts	NULL
(	NULL
Hill	NULL
and	NULL
Treisman	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
NFAT	NULL
is	NULL
controlled	NULL
by	NULL
the	NULL
TCR	NULL
by	NULL
a	NULL
mechanism	NULL
involving	NULL
a	NULL
synergistic	NULL
interaction	NULL
of	NULL
p21lras	NULL
and	NULL
calcium	NULL
signals	NULL
.	NULL

Experiments	NULL
using	NULL
an	NULL
inhibitory	NULL
MAPKK-1	NULL
mutant	NULL
indicate	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
MAPKK-1/ERK-1	NULL
,	NULL
-2	NULL
cascade	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
TCR	NULL
activation	NULL
of	NULL
NFAT	NULL
because	NULL
TCR	NULL
stimulation	NULL
of	NULL
NFAT	NULL
was	NULL
prevented	NULL
by	NULL
the	NULL
inhibitory	NULL
form	NULL
of	NULL
MAPKK-1	NULL
.	NULL

However	NULL
,	NULL
activated	NULL
MAPKK-1	NULL
could	NULL
not	NULL
substitute	NULL
for	NULL
p2	NULL
l	NULL
ras	NULL
signals	NULL
and	NULL
synergize	NULL
with	NULL
calcium	NULL
signals	NULL
to	NULL
stimulate	NULL
NFAT	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
inhibitory	NULL
p2lras	NULL
or	NULL
MAPKK-1	NULL
mutants	NULL
on	NULL
thymocyte	NULL
development	NULL
in	NULL
transgenic	NULL
mice	NULL
concluded	NULL
recently	NULL
that	NULL
p21lras	NULL
functions	NULL
in	NULL
T	NULL
cells	NULL
can	NULL
not	NULL
be	NULL
mediated	NULL
solely	NULL
by	NULL
the	NULL
ERK-2	NULL
signalling	NULL
cascade	NULL
(	NULL
Alberola-lla	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Swan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
failure	NULL
of	NULL
the	NULL
activated	NULL
MAPKK-1	NULL
to	NULL
substitute	NULL
for	NULL
activated	NULL
p2lras	NULL
in	NULL
NFAT	NULL
induction	NULL
confirms	NULL
this	NULL
idea	NULL
and	NULL
thus	NULL
clearly	NULL
demonstrates	NULL
that	NULL
additional	NULL
p21ras	NULL
effector	NULL
pathways	NULL
must	NULL
exist	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Recently	NULL
,	NULL
the	NULL
p21ras-related	NULL
GTPase	NULL
Rac-1	NULL
has	NULL
been	NULL
found	NULL
to	NULL
be	NULL
an	NULL
important	NULL
mediator	NULL
of	NULL
oncogenic	NULL
transformation	NULL
by	NULL
Ras	NULL
(	NULL
Qiu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
describe	NULL
a	NULL
role	NULL
for	NULL
Rac-1	NULL
in	NULL
transcription	NULL
factor	NULL
regulation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
dominant	NULL
negative	NULL
mutant	NULL
of	NULL
Rac-1	NULL
did	NULL
not	NULL
suppress	NULL
TCR	NULL
or	NULL
p2lras	NULL
activation	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
ERK-2	NULL
but	NULL
could	NULL
suppress	NULL
TCR	NULL
and	NULL
p2lras	NULL
induction	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
Rac-1-controlled	NULL
signalling	NULL
pathway	NULL
operating	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
ERK-2	NULL
pathway	NULL
to	NULL
mediate	NULL
p2lras	NULL
induction	NULL
of	NULL
AP-1	NULL
and	NULL
NFAT	NULL
.	NULL

Importantly	NULL
,	NULL
experiments	NULL
with	NULL
a	NULL
constitutively	NULL
active	NULL
Rac-1	NULL
mutant	NULL
showed	NULL
that	NULL
Rac-1	NULL
was	NULL
a	NULL
sufficient	NULL
signal	NULL
for	NULL
activation	NULL
of	NULL
AP-1	NULL
,	NULL
although	NULL
the	NULL
active	NULL
Rac-1	NULL
mutant	NULL
could	NULL
not	NULL
substitute	NULL
for	NULL
the	NULL
activated	NULL
p21lras	NULL
mutant	NULL
for	NULL
NFAT	NULL
induction	NULL
.	NULL

Expression	NULL
of	NULL
activated	NULL
MAPKK-1	NULL
in	NULL
T	NULL
cells	NULL
could	NULL
stimulate	NULL
ERK-2	NULL
,	NULL
and	NULL
the	NULL
activated	NULL
Rac-1	NULL
mutant	NULL
can	NULL
stimulate	NULL
parallel	NULL
kinase	NULL
signal	NULL
3929	NULL
E.Genot	NULL
et	NULL
al	NULL
.	NULL

10	NULL
a	NULL
Â»	NULL
do	NULL
waite	NULL
WWW	NULL
Witew	NULL
|	NULL
<	NULL
G-lexA	NULL
Elk-1C	NULL
(	NULL
r	NULL
)	NULL
Â«	NULL
amman	NULL
Â»	NULL
-	NULL
cium	NULL
<	NULL
a	NULL
>	NULL
<	NULL
#	NULL
-lexA	NULL
-	NULL
Elk-1C	NULL
O	NULL
Ras*	NULL
Rac*	NULL
Pdbu	NULL
O	NULL
Ras*	NULL
Rac*t	NULL
Pdbu	NULL
_	NULL
empty	NULL
____	NULL
____	NULL
Rac	NULL
N17	NULL
___	NULL
N	NULL
Lex	NULL
Elk-1G	NULL
none	NULL
Ras*+	NULL
N17Rac	NULL
Pdbu	NULL
Pdbu+	NULL
N17R	NULL
conversion	NULL
CAT	NULL
a	NULL
(	NULL
%	NULL
c	NULL
_	NULL
AP-1	NULL
CAT	NULL
a	NULL
8	NULL
20	NULL
>	NULL
od	NULL
G	NULL
G	NULL
a	NULL
none	NULL
RasÂ®	NULL
Ras*+	NULL
N17Rac	NULL
Pdbu	NULL
Pdbu+	NULL
N17Rac	NULL
p	NULL
NFAT	NULL
CAT	NULL
3	NULL
>	NULL
7	NULL
l	NULL
I	NULL
a	NULL
U	NULL
0	NULL
4	NULL
m	NULL
39	NULL
]	NULL
<	NULL
Z	NULL
none	NULL
Ras*+	NULL
N17	NULL
Ixn	NULL
Idln	NULL
Pdbu+	NULL
N17	NULL
Rn	NULL
+	NULL
ionomycin	NULL
Fig	NULL
.	NULL

6.	NULL
p21	NULL
ras	NULL
regulation	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
requires	NULL
Rac-1	NULL
function	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
pEF	NULL
N	NULL
Lex-Elk-1C	NULL
fusion	NULL
protein	NULL
expression	NULL
construct	NULL
(	NULL
12	NULL
ug	NULL
)	NULL
together	NULL
with	NULL
8	NULL
ug	NULL
of	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
with	NULL
the	NULL
plasmid	NULL
encoding	NULL
activated	NULL
Ras	NULL
(	NULL
8	NULL
ug	NULL
of	NULL
pEF-BOS	NULL
v-Ha-ras	NULL
)	NULL
or	NULL
activated	NULL
Rac	NULL
(	NULL
8	NULL
ug	NULL
of	NULL
pEFplinkV12Rac	NULL
)	NULL
mutants	NULL
and	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
the	NULL
plasmid	NULL
encoding	NULL
the	NULL
inhibitory	NULL
Rac	NULL
mutant	NULL
(	NULL
8	NULL
ug	NULL
of	NULL
peDNA1	NULL
N17Rac	NULL
)	NULL
.	NULL

At	NULL
16	NULL
h	NULL
post-transfection	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
Pdbu	NULL
(	NULL
50	NULL
ng/ml	NULL
!	NULL
)	NULL

for	NULL
30	NULL
min	NULL
.	NULL

Total	NULL
cell	NULL
extracts	NULL
were	NULL
made	NULL
and	NULL
run	NULL
on	NULL
SDS-PAGE	NULL
.	NULL

The	NULL
data	NULL
show	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
LexA-Elk-1C	NULL
with	NULL
LexA	NULL
antisera	NULL
.	NULL

(	NULL
B	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
and	NULL
(	NULL
D	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
MLV	NULL
N	NULL
Lex-Elk-1C	NULL
(	NULL
6	NULL
ug	NULL
)	NULL
fusion	NULL
protein	NULL
expression	NULL
construct	NULL
and	NULL
its	NULL
reporter	NULL
construct	NULL
LexA-OPtkCAT	NULL
(	NULL
3	NULL
ug	NULL
)	NULL
(	NULL
B	NULL
)	NULL
.	NULL

AP-1-CAT	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
(	NULL
C	NULL
)	NULL
or	NULL
NFAT-CAT	NULL
(	NULL
12	NULL
ug	NULL
)	NULL
(	NULL
D	NULL
)	NULL
reporter	NULL
constructs	NULL
together	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
with	NULL
the	NULL
plasmid	NULL
encoding	NULL
the	NULL
activated	NULL
Ras	NULL
mutant	NULL
(	NULL
15	NULL
ug	NULL
of	NULL
pEF-BOS	NULL
v-Ha-ras	NULL
)	NULL
and	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
2.5	NULL
ug	NULL
of	NULL
the	NULL
plasmid	NULL
encoding	NULL
the	NULL
inhibitory	NULL
Rac	NULL
mutant	NULL
(	NULL
pcDNA1	NULL
N17Rac	NULL
)	NULL
.	NULL

At	NULL
6	NULL
h	NULL
post-transfection	NULL
.	NULL

cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
with	NULL
peDNA1	NULL
Ni7Rac	NULL
alone	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
Pdbu	NULL
(	NULL
50ng/ml1	NULL
)	NULL
for	NULL
16	NULL
h.	NULL
CAT	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
before	NULL
.	NULL

ling	NULL
pathways	NULL
that	NULL
could	NULL
phosphorylate	NULL
and	NULL
transcriptionally	NULL
activate	NULL
Elk-l1	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
activated	NULL
MAPKK-1	NULL
and	NULL
Rac-1	NULL
could	NULL
not	NULL
substitute	NULL
for	NULL
activated	NULL
p21ras	NULL
and	NULL
synergize	NULL
with	NULL
calcium	NULL
signals	NULL
to	NULL
induce	NULL
NFAT	NULL
.	NULL

There	NULL
must	NULL
,	NULL
therefore	NULL
,	NULL
be	NULL
at	NULL
least	NULL
one	NULL
more	NULL
p21lras	NULL
effector	NULL
required	NULL
for	NULL
NFAT	NULL
induction	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

There	NULL
are	NULL
several	NULL
additional	NULL
candidate	NULL
p2lras	NULL
effectors	NULL
including	NULL
the	NULL
GTPase	NULL
Rho	NULL
(	NULL
Prendergast	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
and	NULL
also	NULL
the	NULL
GTPase	NULL
Ral	NULL
(	NULL
Hofer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Spaargaren	NULL
and	NULL
Bischoff	NULL
,	NULL
1994	NULL
)	NULL
,	NULL
whose	NULL
function	NULL
in	NULL
NFAT	NULL
regulation	NULL
remain	NULL
to	NULL
be	NULL
investigated	NULL
.	NULL

p21	NULL
ras	NULL
effects	NULL
on	NULL
the	NULL
MAPKK-1/ERK-2	NULL
cascade	NULL
in	NULL
T	NULL
cells	NULL
are	NULL
mediated	NULL
by	NULL
the	NULL
serine	NULL
kinase	NULL
Raf-1	NULL
(	NULL
Izquierdo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994a	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
clear	NULL
whether	NULL
or	NULL
not	NULL
there	NULL
are	NULL
multiple	NULL
Raf-1	NULL
effector	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
but	NULL
,	NULL
in	NULL
fibroblasts	NULL
,	NULL
Raf-1	NULL
and	NULL
Rac-l	NULL
signals	NULL
synergize	NULL
to	NULL
mediate	NULL
cellular	NULL
transformation	NULL
by	NULL
p2lras	NULL
(	NULL
Qiu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

We	NULL
currently	NULL
are	NULL
exploring	NULL
functional	NULL
interactions	NULL
between	NULL
Raf-1	NULL
and	NULL
Rac-1	NULL
in	NULL
NFAT	NULL
induction	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
Jurkat	NULL
cells	NULL
expressing	NULL
constitutively	NULL
active	NULL
Raf-1	NULL
show	NULL
enhanced	NULL
levels	NULL
of	NULL
IL-2	NULL
production	NULL
but	NULL
there	NULL
has	NULL
not	NULL
been	NULL
a	NULL
direct	NULL
analysis	NULL
of	NULL
the	NULL
role	NULL
of	NULL
Raf-1	NULL
in	NULL
NFAT	NULL
regulation	NULL
(	NULL
Owaki	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Questioning	NULL
how	NULL
p21ras	NULL
would	NULL
regulate	NULL
Rac-1	NULL
,	NULL
a	NULL
couple	NULL
of	NULL
recent	NULL
reports	NULL
raise	NULL
some	NULL
possibilities	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
report	NULL
has	NULL
described	NULL
phosphatidyl	NULL
inositol	NULL
3	NULL
'	NULL
kinase	NULL
(	NULL
PtdIns	NULL
3	NULL
kinase	NULL
)	NULL
as	NULL
an	NULL
upstream	NULL
regulator	NULL
of	NULL
Rac-1	NULL
in	NULL
fibroblasts	NULL
,	NULL
3930	NULL
particularly	NULL
in	NULL
regulating	NULL
cell	NULL
adhesion	NULL
and	NULL
morphology	NULL
(	NULL
Rodriguez-Viciana	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Nobes	NULL
and	NULL
Hall	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
PtdIns	NULL
3	NULL
kinase	NULL
can	NULL
bind	NULL
directly	NULL
to	NULL
activated	NULL
p21	NULL
ras	NULL
,	NULL
and	NULL
function	NULL
as	NULL
an	NULL
effector	NULL
molecule	NULL
for	NULL
p2	NULL
1	NULL
ras	NULL
in	NULL
neuronal	NULL
cells	NULL
(	NULL
Rodriguez-Viciana	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

There	NULL
is	NULL
,	NULL
therefore	NULL
,	NULL
the	NULL
possibility	NULL
that	NULL
PtdIns	NULL
3	NULL
kinase	NULL
could	NULL
be	NULL
the	NULL
link	NULL
between	NULL
Ras	NULL
and	NULL
Rac-1	NULL
.	NULL

Preliminary	NULL
experiments	NULL
show	NULL
that	NULL
PtdIns	NULL
3	NULL
kinase	NULL
inhibitors	NULL
(	NULL
wortmannin	NULL
and	NULL
LY	NULL
294002	NULL
)	NULL
fail	NULL
to	NULL
show	NULL
any	NULL
inhibitory	NULL
effect	NULL
on	NULL
TCR	NULL
induction	NULL
of	NULL
NFAT	NULL
(	NULL
E.Genot	NULL
,	NULL
K.Reif	NULL
and	NULL
D.A.Cantrell	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

The	NULL
failure	NULL
of	NULL
PtdIns	NULL
3	NULL
kinase	NULL
inhibitors	NULL
to	NULL
regulate	NULL
NFAT	NULL
is	NULL
not	NULL
compatible	NULL
with	NULL
a	NULL
role	NULL
for	NULL
PtdIns	NULL
3	NULL
kinase	NULL
as	NULL
a	NULL
mediator	NULL
of	NULL
p2lras	NULL
effects	NULL
on	NULL
NFAT	NULL
.	NULL

Accordingly	NULL
,	NULL
the	NULL
signalling	NULL
links	NULL
between	NULL
p21ras	NULL
,	NULL
PtdIns	NULL
3	NULL
kinase	NULL
and	NULL
Rac-1	NULL
in	NULL
T	NULL
cells	NULL
may	NULL
be	NULL
different	NULL
from	NULL
those	NULL
described	NULL
in	NULL
other	NULL
cell	NULL
lineages	NULL
.	NULL

However	NULL
,	NULL
this	NULL
question	NULL
has	NULL
to	NULL
be	NULL
investigated	NULL
further	NULL
with	NULL
different	NULL
and	NULL
complementary	NULL
approaches	NULL
.	NULL

Concerning	NULL
the	NULL
Rac-1	NULL
effector	NULL
pathway	NULL
for	NULL
NFAT	NULL
induction	NULL
,	NULL
Rac-l-regulated	NULL
protein	NULL
kinases	NULL
have	NULL
now	NULL
been	NULL
identified	NULL
(	NULL
Manser	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Martin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
but	NULL
the	NULL
role	NULL
of	NULL
these	NULL
protein	NULL
kinases	NULL
in	NULL
Rac-l	NULL
effector	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
remains	NULL
to	NULL
be	NULL
discovered	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
used	NULL
in	NULL
the	NULL
present	NULL
experiments	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
complex	NULL
comprising	NULL
a	NULL
member	NULL
of	NULL
the	NULL
NFAT	NULL
group	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
and	NULL
AP-1	NULL
family	NULL
proteins	NULL
(	NULL
Rao	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
AP-1	NULL
u	NULL
Â«	NULL
WW	NULL
?	NULL

jim	NULL
Pï¬Eff	NULL
â	NULL
fV/ï¬ï¬ll	NULL
xngvï¬lfxagcgc-hcybc	NULL
nuit	NULL
(	NULL
Ras	NULL
)	NULL
+-	NULL
@	NULL
JÂ§	NULL
)	NULL
}	NULL
)	NULL
PKC	NULL
ï¬	NULL
Â°	NULL
furl	NULL
;	NULL
\	NULL
\1//\	NULL
P	NULL
V\V	NULL
â	NULL
/	NULL
/	NULL
\	NULL
Ca++	NULL
PKC	NULL
mapPKk1	NULL
/	NULL
A	NULL
f	NULL
5	NULL
Rac-1	NULL
Calcineurin	NULL
NJ	NULL
|	NULL
|	NULL
ERK-	NULL
>	NULL
\	NULL
Â§	NULL
Â¥	NULL
3	NULL
~	NULL
Â¥	NULL
NFAT	NULL
\\	NULL
.	NULL

j	NULL
\_	NULL
@	NULL
I	NULL
.	NULL

\N	NULL
g	NULL
n	NULL
AP-1	NULL
/NFAT	NULL
Â¥	NULL
(	NULL
y	NULL
toklm	NULL
genes	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
signalling	NULL
pathways	NULL
predicted	NULL
to	NULL
induce	NULL
NFAT	NULL
.	NULL

Our	NULL
model	NULL
for	NULL
NFAT	NULL
induction	NULL
shows	NULL
calcium/	NULL
calcineurin	NULL
signals	NULL
regulating	NULL
NFAT	NULL
translocation	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

p2Iras	NULL
/Rac-1	NULL
regulation	NULL
of	NULL
NFAT	NULL
involves	NULL
regulation	NULL
of	NULL
AP-1	NULL
.	NULL

MAPKK-1	NULL
signalling	NULL
pathways	NULL
are	NULL
also	NULL
required	NULL
for	NULL
NFAT	NULL
induction	NULL
and	NULL
,	NULL
since	NULL
MAPKK-1	NULL
does	NULL
not	NULL
regulate	NULL
AP-1	NULL
,	NULL
we	NULL
would	NULL
predict	NULL
that	NULL
MAPKK-1	NULL
pathways	NULL
regulate	NULL
NFAT	NULL
itself	NULL
or	NULL
the	NULL
NFAT	NULL
AP-1	NULL
complex	NULL
.	NULL

To	NULL
explain	NULL
why	NULL
the	NULL
combination	NULL
of	NULL
activated	NULL
MAPKK-1	NULL
and	NULL
activated	NULL
Rac-1	NULL
do	NULL
not	NULL
substitute	NULL
for	NULL
activated	NULL
p21ras	NULL
for	NULL
NFAT	NULL
induction	NULL
,	NULL
we	NULL
have	NULL
to	NULL
evoke	NULL
the	NULL
existence	NULL
of	NULL
at	NULL
least	NULL
one	NULL
more	NULL
p21ras	NULL
signalling	NULL
pathway	NULL
.	NULL

The	NULL
contribution	NULL
of	NULL
PKC	NULL
to	NULL
NFAT	NULL
regulation	NULL
is	NULL
complicated	NULL
because	NULL
the	NULL
TCR	NULL
activates	NULL
PKC	NULL
but	NULL
this	NULL
is	NULL
not	NULL
required	NULL
for	NULL
NFAT	NULL
induction	NULL
.	NULL

Phorbol	NULL
esters	NULL
can	NULL
regulate	NULL
NFAT	NULL
,	NULL
but	NULL
this	NULL
occurs	NULL
by	NULL
an	NULL
independent	NULL
PKC-mediated	NULL
pathway	NULL
that	NULL
converges	NULL
on	NULL
MAPKK-1	NULL
and	NULL
Rac-1	NULL
.	NULL

complex	NULL
is	NULL
composed	NULL
of	NULL
dimers	NULL
of	NULL
members	NULL
of	NULL
the	NULL
Fos	NULL
and	NULL
Jun	NULL
family	NULL
of	NULL
proteins	NULL
.	NULL

The	NULL
exact	NULL
nature	NULL
of	NULL
the	NULL
AP-1	NULL
component	NULL
of	NULL
NFAT	NULL
in	NULL
T	NULL
cells	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
established	NULL
clearly	NULL
.	NULL

Boise	NULL
et	NULL
al	NULL
.	NULL

have	NULL
described	NULL
that	NULL
a	NULL
Fra-l-JunB	NULL
heterodimer	NULL
is	NULL
the	NULL
inducible	NULL
nuclear	NULL
component	NULL
of	NULL
the	NULL
NFAT	NULL
binding	NULL
activity	NULL
,	NULL
while	NULL
Northrop	NULL
et	NULL
al	NULL
.	NULL

have	NULL
reported	NULL
a	NULL
dimer	NULL
composed	NULL
of	NULL
c-Fos	NULL
(	NULL
or	NULL
Fra-1	NULL
)	NULL
and	NULL
either	NULL
c-Jun	NULL
or	NULL
JunD	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
nuclear	NULL
subcomponent	NULL
may	NULL
be	NULL
represented	NULL
by	NULL
a	NULL
heterogeneous	NULL
population	NULL
of	NULL
AP-1-NFAT	NULL
complexes	NULL
(	NULL
Boise	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Northrop	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
clear	NULL
whether	NULL
the	NULL
AP-1	NULL
reporter	NULL
gene	NULL
used	NULL
in	NULL
the	NULL
present	NULL
experiments	NULL
measures	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
AP-1	NULL
components	NULL
of	NULL
NFAT	NULL
or	NULL
of	NULL
distinct	NULL
AP-1	NULL
family	NULL
members	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
present	NULL
AP-1	NULL
reporter	NULL
gene	NULL
data	NULL
are	NULL
valuable	NULL
because	NULL
they	NULL
show	NULL
that	NULL
,	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
Rac-1	NULL
function	NULL
is	NULL
both	NULL
necessary	NULL
and	NULL
can	NULL
be	NULL
sufficient	NULL
for	NULL
AP-1	NULL
induction	NULL
and	NULL
that	NULL
Rac-1	NULL
can	NULL
mediate	NULL
Ras	NULL
effects	NULL
on	NULL
AP-1	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
activated	NULL
Rac-1	NULL
mutants	NULL
were	NULL
equivalent	NULL
to	NULL
the	NULL
activated	NULL
Ras	NULL
mutants	NULL
in	NULL
the	NULL
context	NULL
of	NULL
AP-1	NULL
induction	NULL
.	NULL

This	NULL
role	NULL
of	NULL
Rac-l	NULL
in	NULL
AP-1	NULL
regulation	NULL
could	NULL
thus	NULL
explain	NULL
Rac-1	NULL
requirement	NULL
for	NULL
NFAT	NULL
induction	NULL
.	NULL

Accordingly	NULL
,	NULL
to	NULL
consider	NULL
the	NULL
possible	NULL
Rac-1	NULL
effector	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
necessary	NULL
to	NULL
focus	NULL
on	NULL
the	NULL
mechanisms	NULL
for	NULL
AP-1	NULL
induction	NULL
.	NULL

In	NULL
general	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
results	NULL
from	NULL
increased	NULL
expression	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
family	NULL
proteins	NULL
and	NULL
NFAT	NULL
regulation	NULL
in	NULL
T	NULL
cells	NULL
the	NULL
phosphorylation	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
proteins	NULL
which	NULL
up-regulates	NULL
their	NULL
transcription	NULL
activity	NULL
.	NULL

Several	NULL
parallel	NULL
MAP	NULL
kinase	NULL
signalling	NULL
pathways	NULL
involving	NULL
ERK-1	NULL
,	NULL
-2	NULL
,	NULL
JNK-1	NULL
,	NULL
-2	NULL
and	NULL
MPK2/p38	NULL
and	NULL
a	NULL
Ras-regulated	NULL
Fos	NULL
kinase	NULL
can	NULL
all	NULL
potentially	NULL
contribute	NULL
to	NULL
AP-1	NULL
activation	NULL
(	NULL
Deng	NULL
and	NULL
Karin	NULL
,	NULL
1994	NULL
;	NULL
Cobb	NULL
and	NULL
Goldsmith	NULL
,	NULL
1995	NULL
;	NULL
Coso	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Hill	NULL
and	NULL
Treisman	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
TCF	NULL
Elk-1	NULL
which	NULL
contributes	NULL
to	NULL
increased	NULL
c-fos	NULL
expression	NULL
via	NULL
complex	NULL
formation	NULL
with	NULL
the	NULL
ubiquitous	NULL
transcription	NULL
factor	NULL
SRF	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
the	NULL
ERKs	NULL
and	NULL
JNK-1	NULL
,	NULL
-2	NULL
(	NULL
Marais	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Whitmarsh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

c-jun	NULL
is	NULL
also	NULL
transcriptionally	NULL
regulated	NULL
by	NULL
MAP	NULL
kinase	NULL
pathways	NULL
,	NULL
is	NULL
a	NULL
direct	NULL
substrate	NULL
for	NULL
JNK-1	NULL
and	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
JNK-1-mediated	NULL
phosphorylation	NULL
(	NULL
DÃ©rijard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
suggest	NULL
that	NULL
Rac-1	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
MAP	NULL
kinases	NULL
JNK	NULL
and	NULL
p38	NULL
that	NULL
is	NULL
exactly	NULL
analogous	NULL
to	NULL
the	NULL
role	NULL
of	NULL
p2lras	NULL
in	NULL
the	NULL
ERK	NULL
pathways	NULL
(	NULL
Coso	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Minden	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
present	NULL
data	NULL
show	NULL
that	NULL
Rac-1	NULL
signals	NULL
are	NULL
necessary	NULL
and	NULL
sufficient	NULL
to	NULL
induce	NULL
Elk-1	NULL
phosphorylation	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
indicates	NULL
that	NULL
Rac-1	NULL
signals	NULL
regulate	NULL
transcriptional	NULL
factor	NULL
kinase	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Future	NULL
studies	NULL
will	NULL
establish	NULL
whether	NULL
Rac-1	NULL
effects	NULL
on	NULL
Elk-1	NULL
phosphorylation	NULL
in	NULL
T	NULL
cells	NULL
are	NULL
mediated	NULL
by	NULL
JNK-1/SAPK	NULL
,	NULL
p38	NULL
or	NULL
a	NULL
novel	NULL
protein	NULL
kinase	NULL
pathway	NULL
.	NULL

By	NULL
analogy	NULL
with	NULL
other	NULL
models	NULL
for	NULL
transcription	NULL
factor	NULL
regulation	NULL
by	NULL
p21ras-related	NULL
GTPases	NULL
,	NULL
then	NULL
Rac-l	NULL
effects	NULL
on	NULL
NFAT	NULL
could	NULL
be	NULL
mediated	NULL
by	NULL
one	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
pathways	NULL
.	NULL

Clearly	NULL
Rac-1	NULL
does	NULL
not	NULL
regulate	NULL
ERK-2	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
role	NULL
of	NULL
Rac-1	NULL
in	NULL
TCR	NULL
induction	NULL
of	NULL
NFAT	NULL
involves	NULL
JNK-1/SAPK	NULL
or	NULL
the	NULL
p38	NULL
MAP	NULL
kinase	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
,	NULL
moreover	NULL
,	NULL
that	NULL
the	NULL
role	NULL
of	NULL
Rac-1	NULL
in	NULL
TCR	NULL
induction	NULL
of	NULL
NFAT	NULL
will	NULL
be	NULL
analogous	NULL
to	NULL
the	NULL
role	NULL
of	NULL
Rac-1	NULL
in	NULL
serum	NULL
regulation	NULL
of	NULL
SRF	NULL
transcriptional	NULL
activity	NULL
in	NULL
fibroblasts	NULL
,	NULL
which	NULL
occurs	NULL
by	NULL
an	NULL
unknown	NULL
Rho/Rac-1-controlled	NULL
signalling	NULL
pathway	NULL
that	NULL
does	NULL
not	NULL
involve	NULL
ERK-2	NULL
,	NULL
JNK-1	NULL
or	NULL
p38	NULL
(	NULL
Hill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Rac-1	NULL
may	NULL
mediate	NULL
p2lras	NULL
regulation	NULL
of	NULL
AP-1	NULL
and	NULL
NFAT	NULL
in	NULL
T	NULL
cells	NULL
but	NULL
,	NULL
if	NULL
the	NULL
signalling	NULL
connections	NULL
between	NULL
p2lras	NULL
and	NULL
Rac-1	NULL
in	NULL
T	NULL
cells	NULL
are	NULL
as	NULL
complicated	NULL
as	NULL
those	NULL
in	NULL
fibroblasts	NULL
,	NULL
then	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
p21lras	NULL
and	NULL
Rac-1	NULL
will	NULL
function	NULL
solely	NULL
in	NULL
a	NULL
linear	NULL
signalling	NULL
cascade	NULL
and	NULL
it	NULL
is	NULL
more	NULL
likely	NULL
that	NULL
Rac-1	NULL
and	NULL
p21ras	NULL
will	NULL
function	NULL
in	NULL
both	NULL
parallel	NULL
and	NULL
convergent	NULL
pathways	NULL
.	NULL

Rac-1	NULL
has	NULL
diverse	NULL
roles	NULL
in	NULL
many	NULL
cellular	NULL
systems	NULL
.	NULL

For	NULL
example	NULL
,	NULL
in	NULL
neutrophils	NULL
,	NULL
Rac-1	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NADPH	NULL
oxidase	NULL
complex	NULL
(	NULL
Xu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
fibroblasts	NULL
,	NULL
Rac-1	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
actin	NULL
cytoskeleton	NULL
(	NULL
Nobes	NULL
and	NULL
Hall	NULL
,	NULL
1995	NULL
)	NULL
but	NULL
can	NULL
also	NULL
regulate	NULL
transcriptional	NULL
activity	NULL
of	NULL
SRF	NULL
and	NULL
controls	NULL
c-jun	NULL
transcriptional	NULL
activity	NULL
via	NULL
activation	NULL
of	NULL
the	NULL
c-Jun	NULL
kinases	NULL
JNK-1/SAPK	NULL
(	NULL
Coso	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Hill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Minden	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
JNK-1	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
an	NULL
integration	NULL
point	NULL
for	NULL
signals	NULL
from	NULL
the	NULL
co-stimulatory	NULL
receptor	NULL
CD28-	NULL
and	NULL
TCR-mediated	NULL
calcium/calcineurin	NULL
signals	NULL
(	NULL
Su	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

It	NULL
will	NULL
thus	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
in	NULL
future	NULL
studies	NULL
whether	NULL
Rac-1	NULL
is	NULL
an	NULL
integration	NULL
point	NULL
for	NULL
TCR	NULL
and	NULL
CD28	NULL
signals	NULL
for	NULL
JNK-1/SAPK	NULL
activation	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
the	NULL
present	NULL
study	NULL
has	NULL
examined	NULL
p21ras	NULL
effector	NULL
pathways	NULL
in	NULL
a	NULL
T	NULL
cell	NULL
line	NULL
Jurkat	NULL
in	NULL
an	NULL
attempt	NULL
to	NULL
characterize	NULL
the	NULL
signals	NULL
contributed	NULL
by	NULL
p21ras	NULL
for	NULL
activation	NULL
of	NULL
NFAT	NULL
.	NULL

One	NULL
p2lras	NULL
effector	NULL
pathway	NULL
involves	NULL
MAPKK-1	NULL
,	NULL
which	NULL
is	NULL
shown	NULL
by	NULL
the	NULL
present	NULL
data	NULL
to	NULL
be	NULL
both	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
activation	NULL
of	NULL
ERK-2	NULL
and	NULL
the	NULL
3931	NULL
E.Genot	NULL
et	NULL
al	NULL
.	NULL

transcription	NULL
factor	NULL
Elk-1	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Rac-	NULL
!	NULL

is	NULL
a	NULL
sufficient	NULL
and	NULL
necessary	NULL
signal	NULL
for	NULL
AP-1	NULL
activation	NULL
and	NULL
also	NULL
appears	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
p2lras	NULL
effector	NULL
pathways	NULL
in	NULL
Jurkat	NULL
,	NULL
since	NULL
p21lras-mediated	NULL
induction	NULL
of	NULL
AP-1	NULL
and	NULL
NFAT	NULL
requires	NULL
Rac-1	NULL
function	NULL
.	NULL

MAPKK-1-	NULL
and	NULL
Rac-	NULL
!	NULL

-mediated	NULL
signals	NULL
may	NULL
be	NULL
sufficient	NULL
for	NULL
either	NULL
ERK-2	NULL
or	NULL
AP-1	NULL
activation	NULL
but	NULL
,	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
,	NULL
they	NULL
can	NULL
not	NULL
substitute	NULL
fully	NULL
for	NULL
p21ras	NULL
signals	NULL
for	NULL
induction	NULL
of	NULL
NFAT	NULL
.	NULL

There	NULL
must	NULL
,	NULL
therefore	NULL
,	NULL
be	NULL
at	NULL
least	NULL
one	NULL
more	NULL
p21	NULL
ras	NULL
effector	NULL
pathway	NULL
that	NULL
is	NULL
required	NULL
for	NULL
NFAT	NULL
induction	NULL
.	NULL

The	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
used	NULL
in	NULL
the	NULL
present	NULL
study	NULL
has	NULL
proved	NULL
to	NULL
be	NULL
a	NULL
valuable	NULL
model	NULL
system	NULL
for	NULL
studies	NULL
of	NULL
NFAT	NULL
regulation	NULL
.	NULL

It	NULL
would	NULL
thus	NULL
seem	NULL
likely	NULL
that	NULL
there	NULL
will	NULL
be	NULL
multiple	NULL
Ras	NULL
effectors	NULL
in	NULL
normal	NULL
T	NULL
cell	NULL
populations	NULL
that	NULL
contribute	NULL
to	NULL
NFAT	NULL
regulation	NULL
and	NULL
hence	NULL
cytokine	NULL
gene	NULL
induction	NULL
.	NULL

This	NULL
is	NULL
analogous	NULL
to	NULL
the	NULL
transformation	NULL
of	NULL
fibroblasts	NULL
where	NULL
Ras	NULL
effects	NULL
are	NULL
mediated	NULL
by	NULL
multiple	NULL
effectors	NULL
.	NULL

The	NULL
Rac-1	NULL
effector	NULL
pathway	NULL
for	NULL
NFAT	NULL
induction	NULL
is	NULL
not	NULL
yet	NULL
character-ized	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
NFAT	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
are	NULL
important	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cytokine	NULL
genes	NULL
and	NULL
hence	NULL
important	NULL
for	NULL
a	NULL
successful	NULL
immune	NULL
response	NULL
.	NULL

The	NULL
present	NULL
data	NULL
predict	NULL
that	NULL
Rac-1	NULL
and	NULL
Rac-1	NULL
signalling	NULL
pathways	NULL
would	NULL
be	NULL
important	NULL
targets	NULL
for	NULL
immune	NULL
inter-vention	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Reagents	NULL
Ionomycin	NULL
(	NULL
Ca	NULL
``	NULL
*	NULL
salt	NULL
)	NULL
and	NULL
phorbol-12.13	NULL
dibutyrate	NULL
were	NULL
from	NULL
Calbio-chem	NULL
Corp.	NULL
(	NULL
UK	NULL
)	NULL
.	NULL

[	NULL
14CJAcetyl	NULL
coenzyme	NULL
A	NULL
(	NULL
at	NULL
50-60	NULL
mCi/mmol	NULL
)	NULL
was	NULL
from	NULL
Amersham	NULL
International	NULL
(	NULL
Buckinghamshire	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Other	NULL
reagents	NULL
were	NULL
from	NULL
Sigma	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
UCHT-1	NULL
and	NULL
9E10	NULL
reactive	NULL
with	NULL
human	NULL
CD3	NULL
and	NULL
the	NULL
c-Myc	NULL
epitope	NULL
used	NULL
a	NULL
tag	NULL
for	NULL
ERK-2	NULL
were	NULL
affinity	NULL
purified	NULL
from	NULL
hybridoma	NULL
supernatants	NULL
at	NULL
LC.R.F	NULL
,	NULL
Rabbit	NULL
antisera	NULL
specific	NULL
for	NULL
Lex	NULL
A	NULL
were	NULL
a	NULL
gift	NULL
of	NULL
Richard	NULL
Treisman	NULL
and	NULL
Alberto	NULL
Gandarillas	NULL
(	NULL
ICRF	NULL
)	NULL
.	NULL

Polyclonal	NULL
rabbit	NULL
anti-mouse	NULL
and	NULL
goat	NULL
anti-rabbit	NULL
antibodies	NULL
are	NULL
from	NULL
Amersham	NULL
International	NULL
(	NULL
Buckinghamshire	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Plasmid	NULL
constructs	NULL
The	NULL
reporter	NULL
construct	NULL
AP-	NULL
1-CAT	NULL
,	NULL
containing	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
sequence	NULL
for	NULL
the	NULL
AP-1	NULL
site	NULL
inserted	NULL
in	NULL
pBLCAT2	NULL
.	NULL

has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
Williams	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

LexA-OPtkCAT	NULL
contains	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
LexA	NULL
reporter	NULL
,	NULL
NFAT-CAT	NULL
contains	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
TAAGGAGGAAAAACTGTTTCATACAGAAGGCG	NULL
upstream	NULL
of	NULL
the	NULL
IL-2	NULL
minimal	NULL
promoter	NULL
driving	NULL
the	NULL
reporter	NULL
gene	NULL
CAT	NULL
(	NULL
Verweij	NULL
er	NULL
a/	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Plasmids	NULL
directing	NULL
expression	NULL
of	NULL
wild-type	NULL
MAPKK-1	NULL
:	NULL
pEXV	NULL
;	NULL
MAPKKwt	NULL
,	NULL
constitutively	NULL
active	NULL
MAPKK-1	NULL
:	NULL
pEXV	NULL
;	NULL
,	NULL
MAPKK	NULL
217E/	NULL
221E	NULL
,	NULL
the	NULL
dominant	NULL
negative	NULL
MAPKK-1	NULL
:	NULL
pEXV	NULL
;	NULL
,	NULL
MAPKK	NULL
221A	NULL
and	NULL
constitutively	NULL
active	NULL
p2lras	NULL
:	NULL
pEF-BOS	NULL
v-Ha-ras	NULL
or	NULL
pEXV	NULL
;	NULL
v-Ha-ras	NULL
,	NULL
pEF	NULL
BOS	NULL
ERK-2	NULL
tag	NULL
.	NULL

MLV	NULL
N-LexA-Elk-1C	NULL
fusion	NULL
protein	NULL
or	NULL
pEF	NULL
N-LexA-Elk-1C	NULL
fusion	NULL
protein	NULL
,	NULL
have	NULL
already	NULL
been	NULL
described	NULL
(	NULL
Medema	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Cowley	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Leevers	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Price	NULL
et	NULL
al..	NULL
1995a	NULL
)	NULL
.	NULL

The	NULL
active	NULL
and	NULL
dominant	NULL
negative	NULL
mutants	NULL
of	NULL
Rac-1	NULL
(	NULL
V12Rac-l	NULL
and	NULL
N17Rac-1	NULL
)	NULL
have	NULL
also	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
Nobes	NULL
and	NULL
Hall	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

All	NULL
plasmids	NULL
were	NULL
purified	NULL
by	NULL
equilibrium	NULL
centrifugation	NULL
in	NULL
CsCl-ethidium	NULL
bromide	NULL
gradients	NULL
by	NULL
standard	NULL
procedures	NULL
.	NULL

Cells	NULL
and	NULL
transfections	NULL
J-TAg	NULL
,	NULL
a	NULL
subline	NULL
of	NULL
the	NULL
human	NULL
T	NULL
acute	NULL
lymphocytic	NULL
lymphoma	NULL
cell	NULL
line	NULL
Jurkat	NULL
,	NULL
was	NULL
maintained	NULL
in	NULL
RPMI	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
,	NULL
at	NULL
37Â°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
humidified	NULL
air	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
via	NULL
electroporation	NULL
(	NULL
Gene	NULL
pulser	NULL
:	NULL
Bio-Rad	NULL
,	NULL
UK	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
pulsed	NULL
(	NULL
1X	NULL
10	NULL
``	NULL
cells/0.5	NULL
ml	NULL
)	NULL
in	NULL
complete	NULL
medium	NULL
at	NULL
960	NULL
uF	NULL
and	NULL
320	NULL
V.	NULL
Cells	NULL
transfected	NULL
with	NULL
similar	NULL
plasmid	NULL
mixtures	NULL
were	NULL
pooled	NULL
and	NULL
re-aliquoted	NULL
before	NULL
stimulation	NULL
.	NULL

Transfected	NULL
cultures	NULL
were	NULL
incubated	NULL
for	NULL
6	NULL
h	NULL
,	NULL
and	NULL
stimuli	NULL
,	NULL
when	NULL
required	NULL
,	NULL
were	NULL
applied	NULL
for	NULL
an	NULL
additional	NULL
16	NULL
h.	NULL
The	NULL
amounts	NULL
of	NULL
DNA	NULL
transfected	NULL
in	NULL
each	NULL
experiment	NULL
were	NULL
kept	NULL
constant	NULL
by	NULL
adding	NULL
control	NULL
plasmids	NULL
as	NULL
indicated	NULL
.	NULL

3932	NULL
Western	NULL
blot	NULL
analysis	NULL
and	NULL
MBP	NULL
kinase	NULL
assays	NULL
Cells	NULL
cultured	NULL
in	NULL
complete	NULL
medium	NULL
were	NULL
harvested	NULL
at	NULL
different	NULL
times	NULL
after	NULL
transfection	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
RPMI	NULL
alone	NULL
.	NULL

SDS	NULL
was	NULL
added	NULL
to	NULL
1	NULL
%	NULL
final	NULL
concentration	NULL
.	NULL

After	NULL
vortexing	NULL
,	NULL
extracts	NULL
were	NULL
heated	NULL
for	NULL
5	NULL
min	NULL
at	NULL
100Â°C	NULL
.	NULL

Debris	NULL
were	NULL
pelleted	NULL
by	NULL
ultracentrifugation	NULL
for	NULL
30	NULL
min	NULL
at	NULL
90	NULL
000	NULL
r.p.m	NULL
.	NULL

in	NULL
the	NULL
TL100.2	NULL
rotor	NULL
of	NULL
a	NULL
Beckman	NULL
centrifuge	NULL
.	NULL

Proteins	NULL
were	NULL
acetone	NULL
precipitated	NULL
from	NULL
supernatants	NULL
for	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
and	NULL
resuspended	NULL
in	NULL
reducing	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
.	NULL

Disruption	NULL
of	NULL
the	NULL
pellet	NULL
was	NULL
completed	NULL
by	NULL
sonication	NULL
.	NULL

Extracts	NULL
prepared	NULL
from	NULL
equivalent	NULL
numbers	NULL
of	NULL
living	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
on	NULL
10	NULL
%	NULL
gels	NULL
(	NULL
10	NULL
%	NULL
acrylamide-0.27	NULL
%	NULL
bisacrylamide	NULL
)	NULL
,	NULL
unless	NULL
otherwise	NULL
indicated	NULL
.	NULL

Proteins	NULL
were	NULL
transferred	NULL
to	NULL
polyvinyldifluoridine	NULL
membranes	NULL
(	NULL
Immobilon	NULL
,	NULL
Millipore	NULL
)	NULL
by	NULL
overnight	NULL
Western	NULL
blot	NULL
.	NULL

Membranes	NULL
were	NULL
'blocked	NULL
'	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
-0.05	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
(	NULL
PBST	NULL
)	NULL
plus	NULL
5	NULL
%	NULL
milk	NULL
for	NULL
2	NULL
h.	NULL
One	NULL
ug/ml	NULL
of	NULL
9E10	NULL
antibody	NULL
or	NULL
a	NULL
1/1000	NULL
dilution	NULL
of	NULL
LexA	NULL
antisera	NULL
was	NULL
allowed	NULL
to	NULL
react	NULL
with	NULL
the	NULL
membrane	NULL
overnight	NULL
at	NULL
4Â°C	NULL
.	NULL

After	NULL
extensive	NULL
washes	NULL
,	NULL
membranes	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
dilution	NULL
of	NULL
anti-mouse	NULL
(	NULL
1/4000	NULL
)	NULL
or	NULL
anti-rabbit	NULL
IgG	NULL
(	NULL
1/10	NULL
000	NULL
)	NULL
in	NULL
PBST	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
the	NULL
washes	NULL
in	NULL
PBST	NULL
,	NULL
and	NULL
PBS	NULL
,	NULL
membrane-bound	NULL
antibodies	NULL
were	NULL
visualized	NULL
by	NULL
use	NULL
of	NULL
ECL	NULL
Western	NULL
blotting	NULL
detection	NULL
reagents	NULL
(	NULL
Amersham	NULL
)	NULL
and	NULL
Kodak	NULL
XSI	NULL
films	NULL
.	NULL

ERK-2	NULL
tag	NULL
immunoprecipit-ations	NULL
with	NULL
9E10	NULL
antibody	NULL
and	NULL
MBP	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Izquierdo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

CAT	NULL
assays	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
liquid	NULL
scintillation	NULL
method	NULL
of	NULL
Sleigh	NULL
et	NULL
al	NULL
.	NULL

using	NULL
modifications	NULL
(	NULL
Sleigh	NULL
,	NULL
1986	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
5X	NULL
10Â°	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
50	NULL
ul	NULL
of	NULL
0.5	NULL
%	NULL
NP-40	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
pH	NULL
8	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
150	NULL
mM	NULL
NaCl	NULL
for	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

Cellular	NULL
debris	NULL
was	NULL
pelleted	NULL
and	NULL
lysates	NULL
were	NULL
heated	NULL
at	NULL
68Â°C	NULL
for	NULL
10	NULL
min	NULL
before	NULL
use	NULL
.	NULL

Assay	NULL
conditions	NULL
were	NULL
150	NULL
mM	NULL
Tris	NULL
pH	NULL
8	NULL
,	NULL
0.05	NULL
uCi	NULL
[	NULL
'*Clacetyl	NULL
coenzyme	NULL
A	NULL
and	NULL
2	NULL
mM	NULL
chloramphenicol	NULL
.	NULL

After	NULL
18	NULL
h	NULL
at	NULL
37Â°C	NULL
,	NULL
chloramphenicol	NULL
was	NULL
extracted	NULL
with	NULL
ethylacetate	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
radioactivity	NULL
in	NULL
the	NULL
acetylated	NULL
products	NULL
and	NULL
non-acetylated	NULL
substrate	NULL
of	NULL
each	NULL
reaction	NULL
was	NULL
determined	NULL
by	NULL
liquid	NULL
scintillation	NULL
counting	NULL
of	NULL
organic	NULL
and	NULL
aqueous	NULL
phases	NULL
respect-ively	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
chloramphenicol	NULL
acetylation	NULL
is	NULL
calculated	NULL
as	NULL
a	NULL
percentage	NULL
.	NULL

Acknowledgements	NULL
We	NULL
thank	NULL
S	NULL
$	NULL
.Cowley	NULL
and	NULL
C.Marshall	NULL
for	NULL
the	NULL
MAPKK-1	NULL
constructs	NULL
,	NULL
N.Clipstone	NULL
and	NULL
G.Crabtree	NULL
for	NULL
the	NULL
J-TAg	NULL
cell	NULL
line	NULL
,	NULL
R.Treisman	NULL
and	NULL
A.Gandarillas	NULL
for	NULL
LexA	NULL
antibodies	NULL
,	NULL
M.A.Price	NULL
for	NULL
LexA-OPtkCAT	NULL
and	NULL
LexA-Elk-1C	NULL
constructs	NULL
and	NULL
for	NULL
advice	NULL
,	NULL
J.Babbage	NULL
for	NULL
technical	NULL
assistance	NULL
,	NULL
J.Lunan	NULL
for	NULL
help	NULL
with	NULL
the	NULL
manuscript	NULL
and	NULL
all	NULL
members	NULL
of	NULL
the	NULL
Lymphocyte	NULL
Activation	NULL
Laboratory	NULL
for	NULL
helpful	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

E.G	NULL
.	NULL

is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
INSERM	NULL
organization	NULL
.	NULL

S.H	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
.	NULL

This	NULL
work	NULL
was	NULL
funded	NULL
by	NULL
the	NULL
Imperial	NULL
Cancer	NULL
Research	NULL
Fund	NULL
.	NULL

References	NULL
Alberola-lla	NULL
,	NULL
J.	NULL
,	NULL
Forbush	NULL
,	NULL
K.A	NULL
.	NULL

,	NULL
Seger	NULL
,	NULL
R.	NULL
,	NULL
Krebs.E.G	NULL
.	NULL

and	NULL
Perlmutter.R.M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Nature	NULL
,	NULL
373	NULL
,	NULL
620-623	NULL
.	NULL

Baldari	NULL
,	NULL
C.T	NULL
.	NULL

,	NULL
Macchia.G	NULL
.	NULL

and	NULL
Telford	NULL
,	NULL
J.L	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem..	NULL
267	NULL
,	NULL
4289-4291	NULL
.	NULL

Boise	NULL
,	NULL
L.H	NULL
.	NULL

,	NULL
Petryniak	NULL
,	NULL
B.	NULL
,	NULL
Mao	NULL
,	NULL
.X	NULL
.	NULL

,	NULL
June	NULL
,	NULL
C.H	NULL
.	NULL

,	NULL
Wang	NULL
,	NULL
C.	NULL
,	NULL
Lindsten.C.B	NULL
.	NULL

,	NULL
Bravo	NULL
,	NULL
R.	NULL
,	NULL
Kovary.K	NULL
.	NULL

,	NULL
Leiden	NULL
,	NULL
J.M	NULL
.	NULL

and	NULL
Thompson	NULL
,	NULL
C.B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
113	NULL
,	NULL
1911-1920	NULL
.	NULL

Cobb.M	NULL
.	NULL

and	NULL
Goldsmith	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
,	NULL
14843-14846	NULL
.	NULL

Coso,0	NULL
.	NULL

,	NULL
Chiariello.M	NULL
.	NULL

,	NULL
Yu.J.-C.	NULL
,	NULL
Teramoto	NULL
.	NULL

H.	NULL
,	NULL
Crespo	NULL
,	NULL
P.	NULL
,	NULL
Xu	NULL
,	NULL
N..	NULL
MIki.T	NULL
.	NULL

and	NULL
GutkindJ	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Cell	NULL
.	NULL

81	NULL
,	NULL
1137-1146	NULL
.	NULL

Cowley.S..	NULL
Paterson.H	NULL
.	NULL

,	NULL
Kemp.P	NULL
.	NULL

and	NULL
Marshall	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
,	NULL
77	NULL
,	NULL
841-852	NULL
.	NULL

Deng	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Karin	NULL
.	NULL

M.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
,	NULL
371	NULL
,	NULL
171-175	NULL
.	NULL

DÃ©rijard	NULL
,	NULL
B.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Wu	NULL
,	NULL
L-H.	NULL
,	NULL
Barrett	NULL
,	NULL
T.	NULL
,	NULL
$	NULL
u	NULL
,	NULL
B.	NULL
,	NULL
Deng.T	NULL
.	NULL

,	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Davis	NULL
,	NULL
R.J.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
,	NULL
76	NULL
,	NULL
1025-1037	NULL
.	NULL

Flanagan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
CorthÃ©sy	NULL
,	NULL
B..	NULL
Bram.R.J	NULL
.	NULL

and	NULL
Crabtree	NULL
,	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
,	NULL
352	NULL
,	NULL
803-807	NULL
.	NULL

Genot.E.M	NULL
.	NULL

,	NULL
Parker	NULL
,	NULL
PJ	NULL
.	NULL

and	NULL
Cantrell	NULL
,	NULL
D.A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
,	NULL
9833-9839	NULL
.	NULL

Hall	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
10	NULL
.	NULL

31-54	NULL
.	NULL

Hill.C	NULL
.	NULL

and	NULL
Treisman	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Cell	NULL
,	NULL
80	NULL
,	NULL
199-211	NULL
.	NULL

Hill	NULL
,	NULL
C.	NULL
,	NULL
Wynne.J	NULL
.	NULL

and	NULL
Treisman	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Celf	NULL
,	NULL
81	NULL
,	NULL
1159-1170	NULL
.	NULL

Hoey.T..	NULL
Sun.Y.-L..	NULL
Williamson.K	NULL
.	NULL

and	NULL
Xu.X	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
/mmunity	NULL
,	NULL
2	NULL
.	NULL

461-72	NULL
.	NULL

Hofer.F..	NULL
Fields.S..	NULL
Schneider.C	NULL
.	NULL

and	NULL
Martin.G.S	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
.	NULL

11089-11093	NULL
.	NULL

Howe.L.R..	NULL
Leevers.S.J..	NULL
Gomez.N..	NULL
Nakielney.S..	NULL
Cohen.P	NULL
.	NULL

and	NULL
MarshalLC.J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
.	NULL

71	NULL
.	NULL

335-342	NULL
.	NULL

Izquierdo.M..	NULL
Leevers.S.J..	NULL
Marshall.C	NULL
.	NULL

and	NULL
Cantrell.D.A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med..	NULL
178	NULL
.	NULL

1199-1208	NULL
.	NULL

Izquierdo.M..	NULL
Bowden.S	NULL
.	NULL

and	NULL
Cantrell.D	NULL
.	NULL

(	NULL
1994a	NULL
)	NULL
J.	NULL
Exp	NULL
Med..	NULL
180	NULL
.	NULL

1401-106	NULL
.	NULL

Izquierdo.M..	NULL
Leevers.S.J..	NULL
Williams.D.H..	NULL
Marshall.C.J..	NULL
Weiss.A	NULL
.	NULL

and	NULL
Cantrell.D.A	NULL
.	NULL

(	NULL
1994b	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol..	NULL
24	NULL
,	NULL
2462-2468	NULL
.	NULL

Izquierdo-Pastor.M..	NULL
Reif.K	NULL
.	NULL

and	NULL
Cantrell.D	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
.	NULL

16	NULL
.	NULL

159-164	NULL
.	NULL

Leevers.S	NULL
.	NULL

,	NULL
Paterson.H	NULL
.	NULL

and	NULL
Marshall.C	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Nature	NULL
,	NULL
369	NULL
,	NULL
411-414	NULL
.	NULL

Manser	NULL
,	NULL
E..	NULL
Leung.T..	NULL
Salihuddin.H	NULL
.	NULL

,	NULL
Zhao.Z	NULL
.	NULL

$	NULL
.	NULL

and	NULL
Lin.L	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Nature	NULL
.	NULL

367	NULL
.	NULL

410-46	NULL
.	NULL

Marais.R..	NULL
Wynne.J	NULL
.	NULL

and	NULL
Treisman.R	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cel/	NULL
.	NULL

73	NULL
,	NULL
381~393	NULL
.	NULL

Marshall.C.J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Curs	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

,	NULL
4	NULL
,	NULL
82-89	NULL
.	NULL

Martin.G.A..	NULL
Bollag	NULL
.	NULL

A..	NULL
McCormick.F	NULL
.	NULL

and	NULL
Abo.A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
EMBO	NULL
J..	NULL
14	NULL
.	NULL

1970-1978	NULL
.	NULL

Medema.R.H..	NULL
Wubbolts.R	NULL
.	NULL

and	NULL
Bos	NULL
J.L	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol..	NULL
11	NULL
.	NULL

5963-5967	NULL
.	NULL

Minden.A	NULL
.	NULL

,	NULL
Lin.A..	NULL
Claret.F.-X	NULL
.	NULL

,	NULL
Abo.A	NULL
.	NULL

and	NULL
Karin.M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Cell	NULL
.	NULL

81	NULL
.	NULL

1147-1157	NULL
.	NULL

Nobes.C	NULL
.	NULL

and	NULL
Hall	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
CelZ	NULL
.	NULL

81	NULL
.	NULL

53-62	NULL
.	NULL

Northrop.J.P..	NULL
Ullman.K.S	NULL
.	NULL

and	NULL
Crabtree.G.R	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem..	NULL
268	NULL
.	NULL

22917-2925	NULL
.	NULL

NorthropJ..	NULL
Ho.S..	NULL
Chen.L..	NULL
Thomas.D..	NULL
Timmerman.L..	NULL
Nolan.G..	NULL
Admon.A	NULL
.	NULL

and	NULL
Crabtree.G	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Nature	NULL
.	NULL

369	NULL
.	NULL

497-502	NULL
.	NULL

Owaki.H..	NULL
Varma.R..	NULL
Gillis.B..	NULL
Bruder.J.T..	NULL
Rapp.U.R..	NULL
Davis.L.S	NULL
.	NULL

and	NULL
Geppert.T.D	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J..	NULL
12	NULL
.	NULL

4367-4373	NULL
.	NULL

Prendergast.G.C..	NULL
Khosravi-Far.R..	NULL
Solski.P.A..	NULL
Kurzawa.H	NULL
.	NULL

,	NULL
Lebowitz	NULL
.	NULL

PF	NULL
.	NULL

and	NULL
Der.C	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Oncogene	NULL
.	NULL

10	NULL
,	NULL
2289-2296	NULL
.	NULL

Price.L..	NULL
Norman.J..	NULL
Ridley.A	NULL
.	NULL

and	NULL
Koffer.A	NULL
.	NULL

(	NULL
1995a	NULL
)	NULL
Curr	NULL
Biol..	NULL
5	NULL
.	NULL

68-73	NULL
.	NULL

Price	NULL
.	NULL

M..	NULL
Rogers.A	NULL
.	NULL

and	NULL
Treisman.R	NULL
.	NULL

(	NULL
1995b	NULL
)	NULL
EMBO	NULL
J..	NULL
14	NULL
.	NULL

2589-2601	NULL
.	NULL

Qiu.R.G..	NULL
Chen.J..	NULL
Kirn.D..	NULL
McCormick.F	NULL
.	NULL

and	NULL
Symons.M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Nature	NULL
.	NULL

374	NULL
.	NULL

457-459	NULL
.	NULL

Rao	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
,	NULL
15	NULL
.	NULL

274-281	NULL
.	NULL

Rayter.S..	NULL
Woodrow	NULL
.	NULL

M..	NULL
Lucas.S.C..	NULL
Cantrell.D	NULL
.	NULL

and	NULL
Downward.J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
EMBO	NULL
J..	NULL
11	NULL
.	NULL

4549-4556	NULL
.	NULL

Rodriguez-Viciana.P	NULL
.	NULL

,	NULL
_	NULL
Warne.P.H..	NULL
-	NULL
Dhand.R..	NULL
-	NULL
Vanheaesbroeck.B..	NULL
Gout.L..	NULL
Fry.M.J..	NULL
Waterfield.M.D	NULL
.	NULL

and	NULL
Downward.J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Nature	NULL
,	NULL
370	NULL
.	NULL

527-532	NULL
.	NULL

Schreiber.S.L	NULL
.	NULL

and	NULL
Crabtree.G.R	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
.	NULL

13	NULL
.	NULL

136-142	NULL
.	NULL

Sleigh	NULL
.	NULL

M.J.	NULL
(	NULL
1986	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
156	NULL
.	NULL

251-256	NULL
.	NULL

Spaargaren.M	NULL
.	NULL

and	NULL
Bischoff.J.R	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
.	NULL

12609-12613	NULL
.	NULL

Su.B..	NULL
Estela	NULL
.	NULL

J..	NULL
Hibi	NULL
.	NULL

M..	NULL
Kallunki.T	NULL
.	NULL

,	NULL
Karin	NULL
.	NULL

M.	NULL
and	NULL
Ben-Neriah.Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
.	NULL

77	NULL
.	NULL

727-736	NULL
.	NULL

Swan.K.A..	NULL
Albeerola-lla.J..	NULL
Gross.J.A..	NULL
Appleby.M.W..	NULL
Forbush.K.A..	NULL
Thomas.J.F	NULL
.	NULL

and	NULL
PerImutter.R.M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
EMBO	NULL
J..	NULL
14	NULL
.	NULL

276-285	NULL
.	NULL

Verweij.C.L..	NULL
Guidos.C	NULL
.	NULL

and	NULL
Crabtree.G.R	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem..	NULL
265	NULL
.	NULL

15788-15795	NULL
.	NULL

Warne.P..	NULL
Rodriguez-Viciana.P	NULL
.	NULL

and	NULL
Downward.J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
.	NULL

364	NULL
.	NULL

352-355	NULL
.	NULL

Weiss.A	NULL
.	NULL

and	NULL
Littman.D.R	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
.	NULL

76	NULL
.	NULL

263-274	NULL
.	NULL

Whitmarsh.A..	NULL
Shore.P..	NULL
Sharrocks.A	NULL
.	NULL

and	NULL
Davis.R	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Science	NULL
.	NULL

269	NULL
.	NULL

403-407	NULL
.	NULL

Williams.H.D..	NULL
Woodrow.M..	NULL
Cantrell	NULL
.	NULL

A.D.	NULL
and	NULL
Murray.J.E	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Â£	NULL
:	NULL
J.	NULL
Immunol..	NULL
25	NULL
,	NULL
42-47	NULL
.	NULL

Woodrow	NULL
.	NULL

M..	NULL
Clipstone	NULL
.	NULL

and	NULL
Cantrell.D	NULL
.	NULL

(	NULL
1993a	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
178	NULL
.	NULL

1517-1522	NULL
.	NULL

Woodrow	NULL
.	NULL

M..	NULL
-	NULL
Rayter.S..	NULL
Downward.J	NULL
.	NULL

and	NULL
CantrellD.A	NULL
.	NULL

(	NULL
19936	NULL
)	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
150	NULL
.	NULL

1-9	NULL
.	NULL

Xu.X..	NULL
Barry.D..	NULL
Seitleman.J..	NULL
Schwartz	NULL
.	NULL

M.	NULL
and	NULL
Bokoch.G	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem..	NULL
269	NULL
,	NULL
23569-23574	NULL
.	NULL

Zinck.R..	NULL
Cahill	NULL
.	NULL

M..	NULL
Kracht.M..	NULL
Sachsenmaier.C..	NULL
Hipskind.R	NULL
.	NULL

and	NULL
Nordheim.A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol..	NULL
15	NULL
,	NULL
4930-4938	NULL
.	NULL

Received	NULL
on	NULL
December	NULL
13	NULL
,	NULL
1995	NULL
;	NULL
revised	NULL
on	NULL
April	NULL
23	NULL
,	NULL
1996	NULL
NFAT	NULL
regulation	NULL
in	NULL
T	NULL
cells	NULL
3933	NULL

